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Abstract

Signaling mechanisms that control gap junctional coupling between
retinal neurons

Gap junctions between neurons form the structural substrate for electrical synapses.
Connexin 36 (Cx36, and its non-mammalian ortholog connexin 35) is the major neuronal
gap junction protein in the central nervous system (CNS), and contributes to several
important neuronal functions including neuronal synchronization, signal averaging,
network oscillations, and motor learning. Connexin 36 is strongly expressed in the retina,
where it is an obligatory component of the high-sensitivity rod photoreceptor pathway. A
fundamental requirement of the retina is to adapt to broadly varying inputs in order to
maintain a dynamic range of signaling output. Modulation of the strength of electrical
coupling between networks of retinal neurons, including the Cx36-coupled AII amacrine
cell in the primary rod circuit, is a hallmark of retinal luminance adaptation. However,
very little is known about the mechanisms regulating dynamic modulation of Cx36mediated coupling. The primary goal of this work was to understand how cellular
signaling mechanisms regulate coupling through Cx36 gap junctions. We began by
developing and characterizing phospho-specific antibodies against key regulatory
phosphorylation sites on Cx36. Using these tools we showed that phosphorylation of
Cx35 in fish models varies with light adaptation state, and is modulated by acute changes
in background illumination. We next turned our focus to the well-studied and readily
identifiable AII amacrine cell in mammalian retina. Using this model we showed that
vi

increased phosphorylation of Cx36 is directly related to increased coupling through these
gap junctions, and that the dopamine-stimulated uncoupling of the AII network is
mediated by dephosphorylation of Cx36 via protein kinase A-stimulated protein
phosphatase 2A activity. We then showed that increased phosphorylation of Cx36 on the
AII amacrine network is driven by depolarization of presynaptic ON-type bipolar cells as
well as background light increments. This increase in phosphorylation is mediated by
activation of extrasynaptic NMDA receptors associated with Cx36 gap junctions on AII
amacrine cells and by Ca2+-calmodulin-dependent protein kinase II activation. Finally,
these studies indicated that coupling is regulated locally at individual gap junction
plaques. This work provides a framework for future study of regulation of Cx36mediated coupling, in which increased phosphorylation of Cx36 indicates increased
neuronal coupling.
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Chapter 1

Introduction
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Gap Junctions: An Overview
Gap junctions are membrane-bound, dodecameric protein channels that
connect two neighboring cells by forming an aqueous pore through which metabolic and
electrical communication can occur. These channels aggregate into plaques in the lipid
bilayer which contain from tens to thousands of individual gap junctions (Yeager, 2009).
Each individual gap junction is composed of two docked hemichannels, or connexons,
one hemichannel being contributed by each cell in a coupled pair of cells. Each
hemichannel is in turn composed of six protein subunits called connexins, which are
organized as a hexagonal ring to form the pore (Yeager, 2009). Connexin subunits each
contain four transmembrane domains, as well as two characteristic extracellular loops
which mediate the docking interaction (Yeager, 2009). The remaining intracellular
components (N-terminus, intracellular loop, and C-terminal tail) show considerable
variability across different connexin genes and are targets for regulation of the protein
(Lampe and Lau, 2004).
The human connexin gene family has 21 members, while only 20 are known
in mice (Beyer and Berthoud, 2009). Connexin genes are expressed in virtually every
tissue in the body over the course of development, and in adulthood gap junctions are
found in most organs. A number of connexin genes are also linked to diseases, which
due to the wide expression of the various connexin proteins range from genetic
neuropathies to various skin diseases, from congenital deafness to cataracts (Beyer and
Berthoud, 2009). The work presented hereafter will focus on the role of gap junctions in
the central nervous system (CNS).
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Gap Junctions in Neurons: Basic Properties
Gap junctions between neurons form the structural substrate for electrical
synapses. Because gap junctions form aqueous pores which are permeable to the
common ions used by neurons to control their membrane voltage (Na+, K+, Ca2+, Cl-),
when two neurons coupled by a gap junction have unequal membrane potentials current
will flow through the gap junction proportional to the size of the voltage difference. Thus
gap junctions between neurons act as Ohmic resistors.
Communication between two neurons through electrical synapses contrasts in
several ways with the more common chemical synapses. First, electrical synapses are
faster than chemical synapses since there is no delay imposed by release, diffusion, and
binding of neurotransmitter molecules to receptors. Second, electrical synapses are
always sign conserving; depolarization of one cell in a coupled pair will always cause a
depolarization in the second coupled cell. Third, electrical synapses do not (in and of
themselves) show signal amplification; depolarization of one cell in a coupled pair will
cause a smaller depolarization in the second coupled cell inversely proportional to the
resistance of the gap junctions. The ratio voltage change in the second cell to voltage
change in the first (initially depolarized) cell is termed the coupling coefficient.
Additionally, when the input resistances of a coupled cell pair are unequal, the cell with
the lower input resistance will exert a greater influence on the cell with the higher input
resistance. Finally, electrical synapses are bidirectional, as a depolarization in either cell
relative to the other will cause current to flow through the gap junctions.
Despite the many differences between electrical and chemical synapses, they
do share some common functional properties, although the underlying causes of the
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properties may be different. For instance, electrical synapses undergo synaptic
potentiation (short- and long-term) and depression (Yang et al., 1990; Pereda and Faber,
1996; Landisman and Connors, 2005), similar to chemical synapses. The major goal of
the research presented herein was to further understand the molecular processes that
underlie regulation of gap junctional coupling in neurons. These processes are likely to
be the basis for potentiation and depression observed at electrical synapses.

Gap Junctions in Neurons: Connexin Identity and Implications for Disease
A number of connexins are expressed in neurons in the CNS, including
Cx30.2, Cx36, Cx37, Cx40, Cx45, Cx50, and Cx57 (Massey et al., 2003; Kreuzberg et
al., 2008; Connors, 2009). Of these, Cx36 is both the best studied and the most widely
expressed in the CNS (Connors, 2009). Cx36 gap junction expression occurs throughout
the brain, but is particularly notable in the retina, olfactory bulb, hippocampus,
cerebellum, cerebral cortex, reticular nucleus of the thalamus, inferior olive, striatum, and
spinal cord (Condorelli et al., 1998). In many of these regions specific cell types coupled
by Cx36 have been identified and studied (Connors, 2009).
Neuronal coupling via gap junctions has been suggested to contribute to the
generation and maintenance of neural synchrony underlying seizures (Carlen et al., 2000;
Perez Velazquez and Carlen, 2000). The gene coding for Cx36 has been associated by
linkage studies with juvenile myoclonic epilepsy (Mas et al., 2004; Hempelmann et al.,
2006), and experimental studies have provided some further support for a role of Cx36 in
epilepsy (Maier et al., 2002). These include observations that induced epileptiform
activity is reduced in Cx36-null mice and altered Cx36 expression in animal models of
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epilepsy (Sohl et al., 2000; Gajda et al., 2003; McCracken and Roberts, 2006).
Additionally, drugs that block gap junctional coupling have anticonvulsive effects in
seizure models, including drugs with partial specificity for Cx36 (Jahromi et al., 2002;
Uusisaari et al., 2002; Gajda et al., 2003; Gajda et al., 2005; Bostanci and Bagirici, 2007).
Thus, understanding the mechanisms which mediate regulated changes in coupling
through Cx36 gap junctions may have future relevance for novel epilepsy interventions.

Connexin 36: Channel Properties
Cx36 gap junctions have the smallest unitary conductance, around 10-15 pS,
measured out of all functional gap junction channels (Srinivas et al., 1999; Teubner et al.,
2000). Coupling through Cx36 gap junctions is relatively insensitive to transjunctional
voltage changes (Srinivas et al., 1999), making them ideal for electrical communication
between neurons. Intracellular acidification causes minor increases in the conductance of
Cx36 gap junctions, while alkilinization causes a somewhat sharper reduction of
conductance (Gonzalez-Nieto et al., 2008). However, modulation of channel
conductance by pH within physiological ranges alters conductance less than 25% from
baseline coupling at pH 7.25.
Studies using small tracer molecules have indicated that Cx36 shows some
charge selectivity, preferentially passing positively charged tracers while restricting
diffusion of negatively charged tracers (Vaney, 1985, , 1991; Mills et al., 2001b;
Charpantier et al., 2007). The preferred tracer for studying Cx36 has been biotin
ethylenediamine (Neurobiotin; MW 286 Da, net charge +1), which readily diffuses
through these junctions. Larger biotin-conjugated tracers show increasingly reduced
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permeability through Cx36 junctions as size increases, with biotin-XX cadaverine (MW
555 Da, net charge +1) showing ~80% reduced permeability (Mills and Massey, 2000).
Negatively charged tracers within the same size range (Lucifer yellow, MW 443 Da, net
charge -2; 6-carboxyfluorescein, MW 376 Da, net charge -1) show very little permeation
of Cx36 gap junctions (Vaney, 1985, , 1991; Charpantier et al., 2007).
Fewer studies have addressed the permeation of Cx36 by more biologically
relevant molecules. It has been shown that Cx36 is relatively impermeant to the second
messenger cAMP (Bedner et al., 2003; Bedner et al., 2006), which is not surprising given
its net negative charge. It is known that Ca2+ permeates Cx36 gap junctions (citations),
which is quite significant for neuronal signaling.

Connexin 36: Role in Neuronal Circuits
Owing to its wide expression throughout the CNS, it is not surprising that a
number of studies have identified important roles of Cx36 in neuronal function. Multiple
types of inhibitory interneurons are electrically coupled in neocortex, where they drive
synchronized inhibition of excitatory neurons (Gibson et al., 1999; Beierlein et al., 2000).
Cx36 gap junctions are critical for the generation of this synchronous inhibition (Deans et
al., 2001). Electrical coupling of neurons in the reticular nucleus of the thalamus by
Cx36 gap junctions likewise mediate correlated spiking patterns within these neurons,
which in turn provide inhibition onto thalamic relay cells (Landisman et al., 2002; Long
et al., 2004). Cx36 gap junctions between neurons in the inferior olive mediate
synchronization of subthreshold membrane oscillations (Long et al., 2002). Loss of Cx36
gap junctions between these olivary neurons causes deficits in cerebellar motor learning
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(Van Der Giessen et al., 2008). Cx36-null mice also show selective impairment of
gamma-frequency oscillation in the hippocampus (Hormuzdi et al., 2001; Buhl et al.,
2003)., which are thought to be involved in binding of spatially separated information
processing.
In the retina, Cx36 gap junctions are expressed by every class of neuron
except horizontal cells (Feigenspan et al., 2001a; Mills et al., 2001b; Hidaka et al., 2002;
Lee et al., 2003; Feigenspan et al., 2004a; Zhang and Wu, 2004; Han and Massey, 2005;
Schubert et al., 2005). Coupling between photoreceptors leads to signal averaging
between neighbors which can lead to significant improvement of the signal to noise ratio
(Schwartz, 1975c; Lamb and Simon, 1976; DeVries et al., 2002) and also expands the
effective voltage response range of rods (Attwell et al., 1987). Additionally, coupling
between rods and cones provides an alternative pathway for rod signals to enter the cone
circuitry (Schwartz, 1975d; Deans et al., 2002; Bloomfield and Volgyi, 2009). Coupling
between retinal ganglion cells, many of which express Cx36 (Pan et al., ; Hidaka et al.,
2002; Schubert et al., 2005), contributes to synchronous spiking activity (Hu and
Bloomfield, 2003).
Perhaps the best known function of Cx36 gap junctions in the retina is
coupling between AII amacrine neurons (Kolb and Famiglietti, 1974; Famiglietti and
Kolb, 1975; Feigenspan et al., 2001a; Mills et al., 2001b; Veruki and Hartveit, 2002a).
AIIs receive excitatory input from rod bipolar cells (Kolb and Famiglietti, 1974; Strettoi
et al., 1990), and share this input with their neighboring AIIs through Cx36 gap junctions.
The AII network also outputs the signal through gap junctions, which are composted of
Cx36 on the AII side, to ON-cone bipolar cells (Kolb and Famiglietti, 1974; Mills and
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Massey, 1995; Mills et al., 2001b; Veruki and Hartveit, 2002b). Since rod bipolar cells
do not synapse onto retinal ganglion cells, loss of Cx36 eliminates transmission through
the primary, high-gain rod photoreceptor pathway (Deans et al., 2002; Volgyi et al.,
2004). In addition to the loss of this direct pathway for ON signals, loss of Cx36 also
eliminates the highest-sensitivity OFF pathway, which relies on glycine release from the
lobular dendrites on AII amacrine cells (Volgyi et al., 2004). Loss of Cx36 does not
directly prevent this inhibitory output from the AII, but rather lowers its sensitivity to
light. This is because coupling between AIIs is thought to underlie summation of
synchronous signals and subtraction of asynchronous noise at very low light-levels, thus
increasing the overall sensitivity of the cells output (Smith and Vardi, 1995; Vardi and
Smith, 1996; Bloomfield and Volgyi, 2004).

The Retina: An Overview
Human vision begins when photoreceptor neurons in the retina transduce
absorbed photons into electrical signals. These signals diverge from a small number of
photoreceptor types (one high-sensitivity rod photoreceptor and three [or two to five, in
other vertebrates] lower-sensitivity cone photoreceptor types with differing spectral
sensitivities) at glutamatergic synapses onto a larger number (roughly 10, depending on
species) of bipolar cell types. Bipolar cell types are broadly classified into types that
depolarize to light increments (ON-types, which includes the single type of rod bipolar
cell), and types that hyperpolarize to light (OFF-types). Signals in bipolar cells then
diverge further at glutamatergic synapses onto a larger number (between 15 and 20,
depending on species) of ganglion cell types. These ganglion cells then output the
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information processed in the retina to the rest of the brain as spike trains carried along
their axons, forming a number of parallel information pathways equal to the number of
ganglion cell types (Roska and Werblin, 2001; Dacey et al., 2003; Roska et al., 2006;
Field and Chichilnisky, 2007). Each pathway carries information extracted from
particular components that make up the visual environment, which will then be further
processed by higher-order neurons in the brain to give rise to visual perception (Roska
and Werblin, 2001; Dacey et al., 2003; Roska et al., 2006; Field and Chichilnisky, 2007).
In addition to fundamental differences in the biophysical properties of
photoreceptors, bipolar cells, and ganglion cells, two key components of retinal circuitry
necessary for fine-tuning each parallel pathway are horizontal and amacrine cell
inhibitory interneurons. Horizontal cells (between 2 and 4, depending on species) and
amacrine cells (25 types and up, depending on species) are thought to contribute largely
to the spatial and temporal processing properties of photoreceptors, bipolar cells, and
ganglion cells (Roska and Werblin, 2001; Roska et al., 2006; Field and Chichilnisky,
2007).

The Necessity of Adaptation
In addition to the divergence of photoreceptor signals detailed above, there is
also a high degree of convergence evident in many retinal pathways, especially the rod
photoreceptor pathway (Volgyi et al., 2004; Dunn et al., 2006). Because signals from up
to 10,000 rods may converge onto one ganglion cell the retina has exquisite sensitivity to
light, but is also in constant danger of saturation (Dunn et al., 2006). And although the
various specializations of the retina allow us to perceive the visual world over at least a
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109-fold range of background light intensities, the output range of retinal ganglion cells
(in terms of spike rate modulation) is only 102 (Rodieck, 1998; Rieke and Rudd, 2009).
Thus adaptation is absolutely necessary to preserve dynamic range of signaling,
preventing saturation yet preserving our ability to perceive meaningful differences in our
environment. Adaptation takes place at many different levels in the retina, from the
biochemical phototransduction cascade in photoreceptors (Rodieck, 1998) to individual
synapses between retinal neurons (Rieke and Rudd, 2009; Wark et al., 2009). One
hallmark of luminance adaptation in the retina is regulated changes in coupling between
horizontal cells and AII amacrine cells (Xin and Bloomfield, 1997, , 1999; Bloomfield
and Volgyi, 2004).

The Role of Connexin 36 in Retinal Adaptation
Both types of rabbit horizontal cells and AII amacrine cells display inverted
“U”-shaped coupling functions with relation to background light intensity (Xin and
Bloomfield, 1997, , 1999; Bloomfield and Volgyi, 2004). Since horizontal cells do not
use Cx36, the focus here will be on the role of regulated coupling changes in AII
amacrine cells. AIIs are relatively uncoupled in well dark-adapted retina, when ambient
background light is below rod photoreceptor threshold. Increasing background
illumination to just above rod photoreceptor threshold sharply increases coupling, both
electrical (as measured by receptive field size) and tracer (Neurobiotin diffusion), 4 to 5fold. Coupling continues to increase along a much shallower trajectory as background
illumination is raised over several log units, until eventually it again decreases somewhat
sharply back towards baseline levels. As dopamine also uncouples AII amacrine cells via
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activation of D1 receptors (Hampson et al., 1992; Mills and Massey, 1995), and since
dopamine is considered a light-adaptive signal in the retina (Witkovsky, 2004) that is
released by light-stimulation (Mills et al., 2007; Zhang et al., 2007), it is widely thought
that the falloff in coupling at higher background intensities is mediated by dopamine
signaling. Less attention has been given to potential mechanisms underlying the
background light-driven increase in coupling, although it has the appearance of an
activity-dependent process.
Much thought has been given to the functional significance of regulated
changes in AII amacrine cell coupling in retinal adaptation. The prevailing line of
thinking is that AIIs are uncoupled in darkness in order to maximize the effect of any
single-photon absorptions in individual rods. When photons are this scarce, preventing
the lateral spread of depolarization in the AII network will enhance the transfer of the
signal into coupled ON-cone bipolar cells and then on to a ganglion cell. As background
illumination increases to a level reliably above rod threshold, the chance increases that
two rods within a given distance of each other will absorb photons within the same
integration period. In such a case, much enhanced coupling between AIIs will allow the
summation of synchronous signals and subtraction of asynchronous signals, as noted
previously. Computational modeling (Vardi and Smith, 1996) and experimental evidence
(Dunn et al., 2006) support this, demonstrating that coupling in the AII network increases
the signal to noise ratio of the AII’s light response. The further increase in coupling as
lighting increases in the scotopic range may contribute to gain control as well, as
shunting of increasing excitatory currents in AIIs caused by increasing rod bipolar input
may help to prevent saturation. Finally, as background light enters the cone-
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photoreceptor operating range, uncoupling of AIIs likely serves a two-fold purpose.
First, it likely optimizes the amount of rod input and cone input mixing in cone bipolar
cells in the mesopic range where both rods and cones are active. Second, as background
light enters the photopic range the AII switches its “duty” and receives its input directly
from coupled ON-cone bipolar cells, triggering release of glycine by the AII onto OFFcone bipolar cells and some ganglion cells (Manookin et al., 2008; Murphy and Rieke,
2008; Munch et al., 2009; van Wyk et al., 2009). Uncoupling of the AII network in this
range will increase the spatial localization of this inhibition when photons are abundant
enough to activate the cone pathways of the retina.

Regulation of Connexin 36: Initial Studies
Coupling at AII-AII gap junctions is preferentially regulated by dopamine
signaling and cAMP-dependent processes, while coupling between AII-cone bipolar gap
junctions is preferentially regulated by nitric oxide signaling and cGMP-dependent
processes (Mills and Massey, 1995). Alteration of protein kinase activity is a common
effector of these pathways, and thus initial studies of the regulation of Cx36 targeted
kinase pathways. Addition of a cAMP analog was shown to reduce currents through
Cx35 gap junctions expressed in Xenopus oocytes, and this reduction required a PKA
consensus sequence (Mitropoulou and Bruzzone, 2003). Further studies in HeLa cells
stably transfected with fish Cx35 identified two phosphorylation sites, Ser110 and Ser276
were required for regulation of coupling by PKA activity (Ouyang et al., 2005).
Activation of PKA caused decreased HeLa coupling in these experiments, while
inhibition of PKA increased coupling. Serine to alanine mutation of either residue alone
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reduced regulation by PKA activity, while mutation of both sites eliminated this
regulation. Repeating these experiments with HeLa cells transiently transfected with
mouse Cx36 showed that this regulation by PKA activity is conserved at both
phosphorylation sites in mammals (our unpublished observations). Several studies have
indicated that multiple kinases can phosphorylate both of these sites in vitro, including
PKA, PKG, and CamKII (Ouyang et al., 2005; Patel et al., 2006; Urschel et al., 2006).
Other kinases are predicted or known to phosphorylate one or the other of these sites
(Ouyang et al., 2005; Urschel et al., 2006). The convergence of multiple kinases,
representing the effectors of various signaling pathways, upon each of these
phosphorylation sites suggests their critical involvement in regulation of Cx36-mediated
coupling.
In addition to phosphorylation, protein-protein interactions are also likely to
contribute to regulation of Cx36-mediated coupling. It is known that calmodulin binds to
the C-terminal tail of Cx36 with a low-micromolar K1/2 for Ca2+ (Burr et al., 2005). The
necessity of this relatively high intracellular concentration of Ca2+ for binding indicates
that this interaction would likely be most common at sites such as synapses, where such
elevations of Ca2+ occur. The functional significance of calmodulin binding to Cx36 is
still not well understood. In addition to calmodulin binding, the tip of the C-terminal tail
of Cx36 is a PDZ-domain binding target (Li et al., 2004). This mediates known
interactions with the PDZ-domain-containing scaffolding protein ZO-1 (Li et al., 2004;
Flores et al., 2008), and potentially with several other scaffolding proteins. This
interaction likely does not regulate Cx36 directly, but evidence suggests that it is
important for localizing regulatory proteins to the site of Cx36 gap junctions. For
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instance, when the tip is truncated, regulation by PKA activity is reversed, such that
activation of PKA leads to increased coupling and vice versa (Ouyang et al., 2005). Such
interactions may prove to control cell-specific schemes of Cx36 regulation, particularly
those involving different kinase or phosphatase proteins.

Starting Hypotheses
The following work tested several hypotheses concerning the regulation of
Cx36 by phosphorylation in retinal neurons and the signaling pathways responsible for
this regulation. These chapters follow one another fairly linearly as they progress
towards their goal of furthering our understanding of the signaling mechanisms which
control regulated changes in neuronal coupling.
Chapter 2 focuses on the development and characterization of antibodies
specific for Cx35/36 proteins phosphorylated at either of the two key regulatory serine
residues. These antibodies have proven to be uniquely valuable tools for understanding
how Cx36 regulation occurs in physiologically intact systems. Following the
characterization of the antibodies, they are used to test the hypotheses that the
phosphorylation state of Cx36 is modulated by light-adaptation state and also by acute
changes in background illumination.
Chapter 3 seeks to establish the exact relationship between the
phosphorylation state of Cx36 gap junctions and the coupling state of the networks
expressing them. In it we test the hypothesis that dopamine-mediated uncoupling of AII
amacrine cells is mediated by increased phosphorylation of Cx36. The experimental data
generated argued for rejection of this hypothesis. Therefore, we then test the hypotheses
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that dopamine-stimulated uncoupling of AII amacrine cells required PKA activation, and
that PKA-mediated uncoupling of AII amacrine cells required activation of a protein
phosphatase.
Chapter 4 explores the signaling mechanisms responsible for increasing the
coupling of AII amacrine cells. Based on observations of the expression pattern of
NMDA receptors on AIIs, we test the hypotheses that NMDA receptor activation
mediates increased phosphorylation of Cx36, and that such increases in phosphorylation
are mediated by Ca2+ influx and activation of CamKII. Additionally, we test whether
influx of Ca2+ through NMDA receptors is amplified by Ca2+-induced Ca2+-release, and
whether increased phosphorylation is mediated by activation of ON-bipolar cells either
pharmacologically or by light increments.
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Chapter 2

Phosphorylation of connexin 35 at regulatory sites is modulated by
light-adaptation state and acute light increments

The quoted material in this chapter was previously published as:

“Connexin 35/36 is phosphorylated at regulatory sites in the retina”
in
Visual Neuroscience (2007), 24, 363-375.
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Figures 1-5 in this chapter represent experiments performed by my adviser, John
O’Brien, Ph.D. (Figures 1-4), or by a former postdoc in our lab, Xiaofan Li, Ph.D.
(Figure 5). Their careful work to develop and biochemically characterize the phosphospecific antibodies against Cx35/36 laid the foundation for my experiments in the rest of
this chapter, and indeed for the rest of my experiments in this thesis. For this I am
indebted to them.
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Introduction
Gap junctions form a key component of retinal neural circuitry, and
are present in every major class of retinal neuron (Cook and Becker, 1995). The
identity of several connexins that form retinal gap junctions has been elucidated in
the last decade. Connexin 35/36 (O'Brien et al., 1996; Condorelli et al., 1998;
O'Brien et al., 1998) was the first neuron-specific connexin identified. It has been
found in a large number of neurons in the retina and central nervous system. In
the retina this connexin is associated with AII amacrine cell gap junctions
(Feigenspan et al., 2001b; Mills et al., 2001a), cone photoreceptor gap junctions
(Feigenspan et al., 2004b; O'Brien et al., 2004), and rod photoreceptor gap
junctions in some species (Zhang and Wu, 2004). It is also apparent that a large
number of other neurons use this connexin (O'Brien et al., 2004). Disruption of
the Cx36 gene in mice results in deficits in visual transmission through the rod
pathway (Guldenagel et al., 2001; Deans et al., 2002), consistent with disruption
of AII amacrine-cone ON bipolar cell and rod-cone gap junctions. Cx36-null
mice also showed impaired firing synchrony in the neocortex (Deans et al., 2001)
and gamma-frequency oscillations in the hippocampus (Hormuzdi et al., 2001), as
well as anomalous patterns of sharp-wave bursts and ripple oscillations in the
hippocampus (Maier et al., 2002; Pais et al., 2002).
Electrical coupling forms functional networks within which signals are
shared, and can have many consequences. For example, gap junctions between
photoreceptors spread responses through adjacent terminals, improving the
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signal:noise ratio under many conditions (Schwartz, 1975a; Lamb and Simon,
1976), and expanding the voltage range through which a synaptic response is
possible (Attwell et al., 1987). Rod-cone gap junctions also provide a pathway
through which high-sensitivity rod signals may enter the cone pathways and
chromatic or high frequency cone signals may enter the rod pathway (Schwartz,
1975b; Wu and Yang, 1988; Krizaj et al., 1998).
During visual adaptation the extent of coupling between cells is
modulated, which has significant effects on the sensitivity and resolution of the
retina. Light adaptation has profound effects on receptive field size and tracer
coupling in cone-driven horizontal cells (Baldridge and Ball, 1991; Lankheet et
al., 1993; Bloomfield et al., 1995) and AII amacrine cells (Bloomfield et al.,
1997). Smaller but still significant changes are observed in some photoreceptors.
Cone-cone coupling increases with light adaptation in the turtle (Copenhagen and
Green, 1987), as does rod-cone coupling in salamander (Yang and Wu, 1989).
These changes influence the functional efficacy of the output synapse (Smith et
al., 1986) as well as rod input into the cone system.
The effect of light on photoreceptors is partially mimicked by
dopamine D2/D4-like receptor activation (Krizaj et al., 1998), which results in
reduction of adenylyl cyclase activity and cytoplasmic cAMP concentration
(Cohen et al., 1992; Nir et al., 2002). In other retinal networks, the opposite
effect is mediated by dopamine D1-type receptors. This effect results from
elevation of cytoplasmic cAMP and is mediated by cAMP-dependent protein
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kinase (PKA). It uncouples gap junctions in horizontal cells (Lasater, 1987;
DeVries and Schwartz, 1989) and AII amacrine cells (Hampson et al., 1992).
The effect of PKA activity on coupling in AII amacrine cells has been
duplicated with Cx35 stably expressed in a mammalian cell line (Ouyang et al.,
2005). Activation of PKA causes uncoupling while PKA inhibition causes an
increase in coupling. Uncoupling requires phosphorylation at two sites on Cx35,
Ser110 in the intracellular loop and Ser276 in the carboxyl terminal tail. These
same two sites are also the target of phosphorylation by cGMP-dependent protein
kinase (PKG) in vitro, suggesting that several signaling pathways may converge
on these regulatory residues (Patel et al., 2006). We reasoned that the
phosphorylation state of Ser110 and Ser276 should be indicative of the degree of
coupling possible through Cx35 gap junctions. In this study we made antibodies
against the two regulatory phosphorylation sites of Cx35 and examined whether
these sites are phosphorylated in the retina. A previous study has suggested that
Cx36 is not phosphorylated in bovine retina (Sitaramayya et al., 2003). However,
our study finds that it is phosphorylated in both fish and mammalian retina, and
that phosphorylation state varies with lighting conditions.

Methods
Sequence analysis
DNA sequences obtained from GenBank were analyzed with
GeneTool software (Biotools, Inc., Edmonton, AB) and translated to amino acid
sequences. Amino acid sequences were analyzed with PepTool software
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(Biotools) to identify consensus phosphorylation sequences. Some sequence
alignments were performed with Clustal W (Thompson et al., 1994).

Development of phospho-specific antibodies
Phosphorylated synthetic peptides corresponding to the two major
regulatory PKA phosphorylation sites of perch Cx35 (Ouyang et al., 2005) were
made at the M.D. Anderson Cancer Center Synthetic Antigen Laboratory. The
sequence of the phosphorylated Ser110 peptide was CKERRYS(PO4)TVYLT and
the sequence of the phosphorylated Ser276 peptide was CARRKS(PO4)IYEIRN.
The corresponding non-phosphorylated peptides were also synthesized. The
phosphorylated peptides were crosslinked to Limulus hemocyanin (Sigma
Chemical Co., St. Louis, MO) via the cysteine thiol group using N-[εMaleimidocaproyloxy] succinimide ester (EMCS; Pierce Chemical Co.,
Rockford, IL). Hemocyanin at 10 mg/ml in 83 mM NaH2PO4, 0.9 M NaCl, 10
mM EDTA, pH 7.2 was derivatized by incubation with 1.5 mg/ml EMCS for 2
hours at 4 ºC, and desalted over Biogel P-10 resin (Bio-Rad Laboratories,
Hercules, CA). For each reaction, 4.8 mg of phospho-peptide was added as dry
solid to approximately 6 mg of derivatized hemocyanin and incubated 4 hrs at
4°C. Crosslinking efficiencies were approximately 50% for phospho-Ser110
peptide and 30% for phospho-Ser276 peptide, as determined by the concentration
of free thiol measured by derivatization with dithionitrobenzoic acid (DTNB;
Sigma) and measurement of absorbance at 412 nm. The hemocyanin-linked
peptides were dialyzed for 20 hrs against PBS (137 mM NaCl, 2.7 mM KCl, 10
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mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4), sterile filtered, and sent to Spring
Valley Laboratories (Sykesville, MD) for development of antisera in rabbits.
Bleeds were screened for cross-reactivity with phosphorylated and nonphosphorylated Cx35 by western blot against in vitro phosphorylated Cx35
intracellular loop or carboxyl terminal domain fusion proteins (see below for
methods).
Bleeds showing significant reactivity against phosphorylated Cx35
were affinity purified. To prepare affinity columns, approximately 3 mg of the
phosphorylated and non-phosphorylated peptides were coupled to Sulfolink
columns (Pierce) according to the manufacturer’s instructions. Linking
efficiencies ranged from 80% for non-phospho-Ser110 to 95% for phosphoSer276. Antibodies were affinity purified by a modification of the method of
(Tsang and Wilkins, 1991). 25-50 ml of serum were diluted with an equal volume
of PBS and the following additions were made: 1% phosphatase inhibitor cocktail
(Sigma), 4 μg/ml aprotinin, 4 μg/ml leupeptin, 10 mM benzamidine, 10 mM NaF,
and 0.15% Igepal CA-630. The diluted sera were passed over the phosphopeptide
columns twice, and the columns washed with 100 ml BBS (1 M NaCl, 100 mM
boric acid, 20 mM Na borate, 0.1% Tween-20), followed by 6 ml HBS (25 mM
Hepes, pH 7.4, 0.25 M NaCl, 0.01% NaN3). The columns were then eluted with
15 ml EtMg (3 M MgCl2, 25% ethylene glycol, 75 mM Hepes, pH 7.2), followed
by 6 ml 0.1 M acetic acid, 0.1 M NaCl, 25% ethylene glycol. The acid eluate was
immediately neutralized by addition of 1 M Tris base until the pH was >7. The
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eluates were combined and dialyzed for 20 hr against PBS plus 0.05% NaN3 and
0.05% Igepal CA-630.
Dialyzed, affinity-purified antibodies were passed over the
corresponding non-phosphopeptide columns twice and the flow-through fractions
were concentrated using Centriprep centrifugal filtration devices (Millipore,
Billerica, MA). Antibodies that bound to the non-phosphopeptide columns were
washed, eluted, dialyzed, and concentrated as before to obtain “pan-specific”
antibody fractions.

In vitro phosphorylation
GST fusion proteins containing the cytoplasmic intracellular loop and
carboxyl terminal domains of perch Cx35 (Burr et al., 2005; Ouyang et al., 2005)
were expressed in E. coli strain BL21 and purified by binding to glutathione
sepharose 4B (Amersham, Piscataway, NJ). Fusion proteins (0.5 to 1 μg protein
per reaction) were incubated with 0.5 units cAMP-dependent protein kinase
(PKA) catalytic subunit (mouse α isoform; New England Biolabs, Beverly, MA)
for 90 min. at 37°C. The final solution contained 50 mM Tris-Cl (pH 7.5), 10
mM MgCl2, 300 μM ATP, 27 mM NaCl, 0.5 mM KCl, 2 mM Na2HPO4, 0.3 mM
KH2PO4, and 10% glycerol. The incubation mixtures were dissolved in an equal
volume of 2x SDS sample buffer, electrophoresed in varying amounts, and blotted
to nitrocellulose membranes for screening antisera and affinity-purified
antibodies.
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Retinal membrane preparations
Hybrid striped bass (Morone saxatilis/M. americana) were obtained
from the Texas A&M University Department of Wildlife and Fisheries Sciences
and were maintained in circulating tanks in the laboratory on a 12hr light:12hr
dark cycle. Fish were taken either 2 hr prior to the onset of light (dark-adapted)
or 2 hr after the onset of light (light-adapted), anesthetized with 0.3% 2aminobenzoic acid methyl ester (Sigma), and sacrificed. Retinas were dissected
out and homogenized by sonication in ice-cold 0.32 M sucrose, 10 mM Tris-Cl,
pH 7.2, 2 mM EGTA, 5 mM MgCl2, 1 μM okadaic acid, 1% protease inhibitor
cocktail (Sigma). For dark eyes, procedures were performed under dim red
safelight illumination through the homogenization steps. The suspension was
centrifuged for 5 min at 1000 x g to remove large particulates, and then the
supernatant was centrifuged for 1 hr at 100,000 x g to pellet membranes. The
membrane pellet was resuspended in the homogenization medium without
protease or phosphatase inhibitors. Protein concentration was measured by the
BCA technique (Pierce).
Daytime, light-adapted rabbit eyes were obtained from Dr. Michael
Mauk (University of Texas Medical School at Houston) from animals sacrificed
for other experiments. Retinas were dissected out and membrane preparations
made as for hybrid bass. Daytime, light-adapted mouse eyes were obtained from
Dr. Steven Wang (University of Texas Medical School at Houston) from animals
sacrificed for other experiments. Membrane preparations were prepared in a
similar manner except that high-speed centrifugation was performed in a
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Beckman airfuge for 30 min at approximately 100,000 x g. All procedures
performed on animals were approved by the institutional animal care and use
committee.
For each membrane preparation, a portion of the preparation was
digested with bacterial alkaline phosphatase. The membrane preparations were
diluted to 2 mg protein/ml with alkaline phosphatase assay buffer (final buffer
composition 10 mM Tris-Cl, 10 mM MgCl2, 0.5% Igepal CA-630, plus 15-28%
of the membrane homogenization buffer), and digested with 17-25 units alkaline
phosphatase (Fermentas, Hanover, MD) per mg protein for 30 min at 37ºC plus an
additional 2 hr at 50ºC. The samples were then diluted to 1 mg protein/ml with 2x
SDS sample buffer. Comparable non-digested samples were prepared at the same
concentration with alkaline phosphatase buffer but no enzyme.

Western blot
Samples of in vitro phosphorylated fusion proteins or retinal
membrane preparations were resolved on SDS-PAGE minigels by standard
procedures. Proteins were transferred to nitrocellulose (for in vitro
phosphorylated proteins) or PVDF (for retinal membrane preparations)
membranes electrophoretically. For screening crude antisera, portions of the blots
were incubated with dilutions of crude serum ranging from 1:500 to 1:50,000 in
TBST (137 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 0.1% Tween-20).
Signals were developed with Cy3-conjugated secondary antibodies (Jackson
Immunoresearch, West Valley, PA) and viewed with a Typhoon imager (GE
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Healthcare Bio-Sciences, Piscataway, NJ). For retinal membrane preparations,
blots were incubated with affinity purified phospho-specific antibodies diluted to
1 μg/ml in high-salt TBST (500 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4,
0.1% Tween-20) plus 2% nonfat dry milk. Blots were also probed with a
monoclonal anti-Cx35/36 antibody (Chemicon, Temecula, CA) that was
developed against the perch Cx35 intracellular loop (O'Brien et al., 2004) at 1
μg/ml in the same solution. Blots were developed with peroxidase-linked
secondary antibodies (Pierce) and detected by chemiluminescence using x-ray
film.

Immunoprecipitation
Daytime, light-adapted bass retinal membrane preparations (240 μg
total protein) were diluted to 400 μl in modified PBST (137 mM NaCl, 3 mM
KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 2 mM EDTA, 1% Triton X-100, 0.5% Na
deoxycholate, pH 7.4) with 1% protease inhibitor cocktail (Sigma) and incubated
with 1 μg mouse anti-Cx36 antibody (Zymed Laboratories, San Francisco, CA) at
4ºC for 4 hr. The protein-antibody mixture was further incubated with 20 μl of
50% slurry of protein G-agarose resin (Amersham) at 4ºC for 1 hr. This mixture
was centrifuged for 5 min at 1000 x g and the pellet was washed three times with
0.5 ml modified PBST and then resuspended in 2x SDS sample buffer for
electrophoresis. The IP supernatant and a sample of the initial lysate were
acetone precipitated to prepare samples for electrophoresis. Western blot of the
samples was performed as above with this modification: the ReliaBlot kit (Bethyl
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Laboratories, Montgomery, TX) was utilized to mask the Ig signal from the
immunoprecipitation antibody according to the manufacturer’s instruction.
Briefly, PVDF membrane with transferred protein samples was blocked in
ReliaBlot blocking reagent and then probed with rabbit anti-phospho-S110
antibodies (1.6 μg/ml in Reliablot blocking reagent) overnight at 4ºC. The blot
was developed with peroxidase-linked secondary antibodies provided in the kit
and detected by chemiluminescence using x-ray film.

Immunostaining
Eyecups were prepared from hybrid striped bass either 2 hr before the
start of the light-cycle under infrared illumination (dark-adapted) or 2 hr after the
start of the light-cycle under normal room lights (light-adapted). The eyecups
were incubated in 2000 units/ml hyaluronidase (Sigma) in PBS for 20 min, and
then washed twice for 15 min each in PBS. Subsequently all eyecups were fixed
for 15 min in fresh 1% N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide
hydrochloride (Sigma) in fixation buffer (116 mM Tris, 68 mM NaCl, 1.3 mM
KCl, 52 mM Na2HPO4, 25 mM NaH2PO4, 0.9 mM KH2PO4, pH 7.5), and then
washed three times for 30 min each in PBS. Eyecups were cryoprotected
overnight at 4ºC in PBS plus 30% sucrose, 0.25% NaN3, embedded in Tissue-Tek
O.C.T. compound (Sakura Finetek, Torrance, CA), and cryosectioned (20 or 40
μm sections). Sections were incubated in PBST (PBS plus 0.5% Triton X-100,
0.1% NaN3) with 10% normal donkey serum (Jackson) for 5 hours to block
nonspecific binding. Sections were then incubated with 2 μg/ml mouse anti-
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Cx35/36 (Chemicon) and either rabbit anti-phospho-Ser110 or rabbit antiphospho-Ser276 (0.8 or 1 μg/ml, respectively) in PBST with 10% normal donkey
serum overnight at 4ºC. Sections were washed three times for 10 min each in
PBST, and then incubated with Cy3-conjugated donkey anti-mouse IgG (Jackson;
1:250 dilution) and Alexa 488-conjugated donkey anti-rabbit IgG (Molecular
Probes, Eugene, OR; 1:250 dilution) for 2.5 hours. Sections were then washed
three times for 10 min each in PBST, mounted with Vectashield (Vector
Laboratories, Burlingame, CA), and imaged on a Zeiss LSM 510 Meta confocal
microscope using 12-bit data acquisition. All specimens were imaged using
similar settings to allow comparison of phospho-antibody labeling in different
parts of the retina and under different conditions. Images presented are stacks of
three confocal slices totaling approximately 1 μm of focal depth. Image
processing (Adobe Photoshop; Adobe Systems, San Jose, CA) was limited to
applying a uniform threshold (approximately 10%) to all images in all color
channels to reduce background haze. One low-power overview image was
brightened (figure 6, phospho-Ser276) to make small gap junction plaques visible.

Quantitative Image Analysis
Medium-power, high-resolution images that included the entire inner
plexiform layer were collected for quantitative analysis using identical confocal
microscope settings. For each condition 3-6 images were collected from each of 3
eyecups which were each from different fish. Images were analyzed with the
same settings using SimplePCI software (Compix, Sewickley, PA) to
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automatically select regions of interest (ROIs) from the Cx35 plaques, as
identified by the mouse anti-Cx35/36 (Chemicon) labeling. Briefly, regions of
interest were defined as contiguous pixels with an intensity threshold greater than
20% of the total intensity range, and which covered a minimum area of 16 pixels
(~0.1 μm2 or larger). Each image was then manually scanned for individual ROIs
that included more than one plaque. These were eliminated from the analysis.
Mean fluorescence intensity was measured in each channel (monoclonal Cx35
labeling; phospho-Cx35 labeling) for each ROI (hereafter called ‘plaques’). The
intensity of phospho-Cx35 antibody labeling was then normalized to the intensity
of the monoclonal Cx35 antibody labeling for each individual plaque. Cx35
plaques were separated into two subgroups for further analysis based on readily
apparent differences between plaques of typical size and “giant plaques” that were
distributed symmetrically in two bands in the IPL. Histograms of plaque size
were generated in Matlab (The MathWorks, Natick, MA) using 250 pixel (~1.225
μm2) bins. A cutoff point (1000 pixels, ~4.9 μm2) was empirically determined
that distinguished the giant plaques apparent upon visual inspection from all other
plaques. For each image the mean normalized phospho-Cx35 intensity of each
population of plaques (“normal” and “giant”) was calculated. Mean values for 36 images per eyecup were averaged to yield a grand mean normalized phosphoCx35 intensity for each population of plaques for each eyecup. Note that each
eyecup represents one animal. Unpaired t-tests were performed to compare
eyecups across conditions.
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Results
Cx35/36 is regulated by phosphorylation at conserved sites
Connexin 35/36 is the most widespread neuronal gap junction protein
in the vertebrate central nervous system. A preponderance of evidence from
retinal neurons suggests that gap junctional coupling through Cx35/36 can be
regulated by environmental conditions such as light exposure and by
neurotransmitter signaling pathways. Comparable regulation has been observed
directly for Cx35 in cell culture expression systems and has been shown to
depend on direct phosphorylation of the connexin (Ouyang et al., 2005; Patel et
al., 2006). The outcomes of these studies indicate that two phosphorylation sites
are critical for regulation of coupling by the cAMP/PKA pathway, and perhaps
the cGMP/PKG pathway as well. Figure 1A shows these two sites, Ser110 in the
intracellular loop and Ser276 in the C-terminal domain (Ser276 in teleost,
amphibian, and avian Cx35 is equivalent to Ser293 of mammalian Cx36 and
Ser273 of skate Cx35), and a putative model of regulation by PKA (adapted from
(Ouyang et al., 2005). In this model, phosphorylation at both Ser110 and Ser276
is required to cause substantial uncoupling of Cx35 gap junctions;
phosphorylation of either residue alone causes only very modest uncoupling
(Ouyang et al., 2005). Furthermore, this behavior can be reversed, i.e.
phosphorylation can lead to increased coupling, under conditions that alter the
interactions at the tip of the C-terminus. The molecular details of this “switch”
are unknown.
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Figure 1. Regulation of Cx35 by phosphorylation.
A. Phosphorylation of Cx35 at two sites, Ser110 (on the intracellular loop) and
Ser276 (on the carboxyl terminus), cause reductions in coupling through Cx35
gap junctions. Phosphorylation at both sites has a nearly 3-fold larger effect than
phosphorylation at either site alone. This regulation can be reversed by altering as
yet unknown interactions with the end of the C-terminal domain. Model adapted
from (Ouyang et al., 2005). B. Alignments of the Cx35/36 sequences
surrounding the regulatory phosphorylation sites from diverse species. Both
regulatory sites are highly conserved. Cx35/36 contains consensus sequences for
phosphorylation by several protein kinases in these domains (listed above the
phosphorylated residues). Phosphorylation by kinases shown in bold has been
verified experimentally (Ouyang et al., 2005; Patel et al., 2006; Urschel et al.,
2006). Amino acid residue numbering is for perch Cx35.
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Figure 1B shows an alignment of Cx35/36 sequences from several
species in the regions surrounding these regulatory phosphorylation sites.
Sequence analysis shows that these regions contain consensus phosphorylation
sequences for a number of different protein kinases, listed above the sequences.
Those that have been verified experimentally (all through in vitro studies) are
shown in bold. It is apparent that the previously identified regulatory
phosphorylation sites are highly conserved across widely divergent vertebrate
species. Furthermore, these sites are potential targets of several protein kinases,
which in turn represent several different signaling pathways. These include
cAMP-dependent protein kinase (PKA), a terminal effector of the dopamine
signaling pathways, and cGMP-dependent protein kinase (PKG), a terminal
effector of nitric oxide signaling, both of which are important in light adaptation
in the retina.

Conserved regulatory phosphorylation sites are phosphorylated in the retina
The convergence of several different signaling pathways on common
regulatory sites suggests that the phosphorylation status of these sites may be used
to estimate the functional state of the gap junctions. To examine this hypothesis
we developed phospho-specific antibodies against both regulatory sites of Cx35.
We examined the specificity of these antibodies with western blots against
bacterially-expressed GST fusion proteins of either the Cx35 intracellular loop
(IL) domain, containing the Ser110 phosphorylation site, or the carboxyl terminal
(CT) domain, containing the Ser276 phosphorylation site. Figure 2A shows a
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Figure 2. Specificity of the phospho-Cx35 antibodies.
Western blot analysis of GST-fusion proteins phosphorylated in vitro with PKA
using two phospho-specific anti-Cx35 antibodies. A. The blot was probed with
polyclonal anti-Cx35 phospho-Ser110. The antibody labeled the Cx35
intracellular loop domain (IL) phosphorylated by PKA (middle lane), but not the
non-phosphorylated IL domain (left lane). The IL domain contains the Ser110
site targeted by this antibody. The antibody also failed to recognize the
phosphorylated Cx35 C-terminus (CT; right lane), which contains the Ser276 site.
B. The blot was probed with polyclonal anti-Cx35 phospho-Ser276 antibody.
This antibody labeled the in vitro phosphorylated Cx35 CT (middle lane), but did
not label the non-phosphorylated CT (left lane). Phosphorylated Cx35 IL (right
lane) was not labeled. Each lane contains 200 ng GST fusion protein.
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western blot with the phosho-Ser110 antibody. This antibody reacted strongly to
the IL domain phosphorylated in vitro with PKA, but showed no measurable
reaction to the non-phosphorylated IL domain. Furthermore, this antibody
showed no cross-reaction with the in vitro phosphorylated Cx35 CT domain.
Thus the antibody was specific for the phosphorylated form of the protein and did
not cross-react with the other major PKA phosphorylation site. Likewise, figure
2B shows a similar western blot with the phospho-Ser276 antibody. As with the
phospho-Ser110 antibody, this antibody was specific for the phosphorylated form
of the protein and did not cross-react with the Ser110 site.
If phosphorylation of Cx35 is involved in regulation of coupling in
retinal neurons, we would predict that both Ser110 and Ser276 sites would be
phosphorylated to some extent in Cx35 derived from the retina. To test this
prediction we performed western blots on membrane preparations from hybrid
bass retina taken in the dark and light parts of their diurnal cycle. We treated half
of each membrane preparation with alkaline phosphatase (AP) to remove
phosphate groups from the protein. A monoclonal antibody against Cx35 (figure
3, panel A) identified Cx35 as a diffuse band running around 30-32 kDa, in
keeping with previous reports (O'Brien et al., 1998; Pereda et al., 2003; O'Brien et
al., 2004). The phospho-Ser110 antibody (panel B) labeled the same band in
untreated retinal membranes. The labeling was lost in AP digested membranes.
Note that this antibody also labeled several high molecular weight bands in retinal
membranes. That labeling was also lost upon AP digestion, suggesting that these
were phosphorylated proteins with PKA phosphorylation sites similar to that of
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Figure 3. Phospho-Cx35 antibodies recognize Cx35 in hybrid bass retinal
membrane preparations.
A. Western blot of membrane preparations from dark-adapted retina (D, left two
lanes) and light-adapted retina (L, right two lanes). A monoclonal antibody
against Cx35 recognized the appropriate band between 30-32 kDa. Digestion of
the membranes with alkaline phosphatase (AP; right lane of each pair) had no
effect on this labeling. B. Western blot of retinal membranes probed with the
phospho-Ser110 antibody. The phospho-Ser110 antibody recognized the same
band identified by the monoclonal antibody in preparations from both dark- and
light-adapted retinas. Labeling by the phospho-Ser110 antibody was lost in
membranes digested with AP. The phospho-Ser110 antibody also recognized
high molecular weight bands in the blot, but labeling was lost with AP digestion
indicating that these are phospho-proteins. C. Western blot of retinal membranes
probed with the phospho-Ser276 antibody. The phospho-Ser276 antibody also
recognized the Cx35 band in both dark- and light-adapted retinal membranes.
Labeling by the phospho-Ser276 antibody was lost in membranes digested with
AP. Each lane contains 40 μg retinal membrane protein.
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Cx35’s Ser110 site. There was little difference in the intensity of phospho-Ser110
labeling on the Cx35 band between dark and light conditions, nor in the total
amount of Cx35 between dark and light conditions. The phospho-Ser276
antibody also recognized the Cx35 band in retinal membranes (panel C), and this
labeling was lost upon AP digestion. No non-specific bands were detected with
this antibody. Again, the difference between dark and light conditions was
minimal. These results suggest that Cx35 is indeed phosphorylated in bass retina
at both regulatory sites.
The regulatory phosphorylation sites of Cx35 are highly conserved
among diverse vertebrate species (e.g. figure 1B), which suggests that regulation
by phosphorylation at these two sites is likely also to be conserved. To test
whether these sites were phosphorylated in other species we examined retinal
membranes from two mammals, mouse and rabbit, for phosphorylation of Cx36
on Ser110 and Ser293 (= Ser276 of teleost Cx35). Figure 4 shows that both
phospho-specific antibodies labeled Cx36 in daytime, light-adapted mouse and
rabbit retinal membranes. This labeling was destroyed by digestion of the
membranes with AP. Although not shown in these blots, labeling of
phosphorylated high molecular weight bands in mouse and rabbit retina was again
evident with the phospho-Ser110 antibody.
Labeling of phospho-proteins other than Cx35 in western blots using
the phospho-Ser110 antibody raises the question of whether this antibody can be
used to examine phosphorylation of Cx35 in intact tissues. It is possible that
labeling of Cx35 gap junctions by the antibody may represent phosphorylation of
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Figure 4. Phospho-Cx35 antibodies recognize Cx36 in mammalian retinal
membranes.
Cx36 was labeled by the Cx35 monoclonal antibody (bottom panel) in western
blots of membrane preparations from light-adapted mouse (left two lanes) and
rabbit (right two lanes) retina. Both the phospho-Ser110 (top panel) antibody and
the phospho-Ser276 antibody (middle panel) recognized the same band identified
by the monoclonal antibody in both species. This labeling was largely lost in
membranes digested with alkaline phosphatase (AP). Each lane contains 40 μg
retinal membrane protein.
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proteins associated with the Cx35 gap junctions rather than actual
phosphorylation of Cx35. To examine this question we performed
immunoprecipitation experiments with the monoclonal anti-Cx35 antibody and
probed the precipitates with the phospho-Ser110 antibody. Figure 5 shows that
the immunoprecipitate containing phosphorylated Cx35 did not contain any of the
high molecular weight phospho-proteins found in the original retinal membrane
preparation. In contrast, the supernatant from the experiment contained the same
complement of high molecular weight phospho-proteins as did the crude
membranes. This implies that the phosphorylated proteins recognized by the
phospho-Ser110 antibody are not associated with Cx35 in a complex, and thus are
not predicted to interfere with analysis of Cx35 gap junctions.

Phosphorylation of Cx35 is controlled at the level of individual gap junctions
We did not see gross changes in Cx35 phosphorylation between dark
and light conditions by western blot analysis. However, it is possible that the
phosphorylation state, and by inference the coupled state, of Cx35 gap junctions
may be regulated at the level of individual gap junctions. To test this hypothesis
we examined hybrid bass retina by confocal immunofluorescence techniques
using the two phospho-specific Cx35 antibodies. Figure 6 shows the pattern of
labeling by the Cx35 phospho-Ser110 antibody (A-C) and the Cx35 phosphoSer276 antibody (D-F) compared to labeling with a Cx35 monoclonal antibody.
Both phospho-Ser110 (A) and phospho-Ser276 (D) antibodies labeled abundant
punctate structures in both inner and outer plexiform layers in a pattern similar to
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Figure 5. Phospho-proteins non-specifically recognized by the phosphoSer110 antibody are not associated with Cx35.
Immunoprecipitation of Cx35 from hybrid bass retinal membrane preparations
using monoclonal anti-Cx35 and probed with anti-phospho-Ser110. The
immunoprecipitate lane (IP) contained phosphorylated Cx35 but none of the high
molecular weight phospho-proteins detected in western blots of retinal
membranes (lysate lane; see also figure 3B). In contrast, the IP supernatant
(super.) contained the same suite of phospho-proteins as found in the lysate. Each
lane contains the equivalent of 90 μg retinal membrane protein.
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that of Cx35 labeling (B and E). In the merged images it is evident that many
Cx35 plaques were also labeled for phospho-Ser110 (C) or phospho-Ser276 (F).
The phospho-Ser110 antibody also showed strong non-specific labeling of Müller
cells (A and C). This labeling was much less apparent, though present to some
extent, in retina from other species (authors’ unpublished observations). The
phospho-Ser276 antibody showed only minor non-specific labeling of blood
vessels in the retina.
Closer examination of the inner plexiform layer revealed that
individual gap junctions labeled with the Cx35 monoclonal antibody (figure 7 B
and C; shown in red) had highly variable labeling for phospho-Ser276 (figure 7 A
and C; green). Some Cx35 plaques showed extensive, bright phospho-Ser276
labeling while others had essentially none (arrow). One readily identifiable group
of Cx35 gap junctions were the extremely large (up to 32 μm2) plaques distributed
in two bands, one each in sublamina a and sublamina b, that we have previously
reported (O'Brien et al., 2004). The cell type harboring these gap junctions is
unknown, although they fit the description of the large gap junctions between
large-caliber amacrine cell processes identified by (Marc et al., 1988) in TEM
studies of goldfish retina. In nighttime, dark-adapted retina these gap junctions
were highly phosphorylated at Ser276 (figure 7 A and C, triple arrowhead).
However, in daytime, light-adapted retina there was much less immunostaining
for phospho-Ser276 on these gap junctions (figure 7 D and F, triple arrowhead).
At the same time one population of medium-sized Cx35 gap junctions still
showed substantial phosphorylation on the Ser276 site (single arrowheads), while
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Figure 6. Phospho-Cx35 antibody labeling patterns in hybrid bass retina.
A. Labeling pattern of phospho-Ser110 antibody in light-adapted hybrid bass
retina. The phospho-Ser110 antibody labeled abundant punctate structures in the
inner and outer plexiform layers (IPL and OPL, respectively). It also strongly
labeled Müller cells, as illustrated here by the bright labeling of their somas above
the IPL and long trunks descending through the IPL. Scale bar is 20 μm; scale is
the same for each image. B. Labeling with the monoclonal Cx35 antibody in the
same section reveals the distribution of Cx35 in the OPL and IPL. C. Merged
image of A and B. Many of the plaques identified as Cx35 by the monoclonal
antibody were also labeled by the phospho-Ser110 antibody (co-localization
shown in yellow). D. Labeling pattern of phospho-Ser276 antibody in lightadapted hybrid bass retina. The phospho-Ser276 antibody also labeled abundant
punctate structures in the IPL and OPL. Minor non-specific labeling resembled
blood vessels in the retina. D. Cx35 monoclonal antibody staining in the same
section shows a largely overlapping distribution of signals. F. Merged image of
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D and E. Many of the plaques identified as Cx35 by the monoclonal antibody
were also labeled by the phospho-Ser276 antibody (co-localization shown in
yellow).
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again others had none (arrow). We could not determine from these data whether
the medium-sized Cx35 gap junctions, some of which were highly phosphorylated
and some non-phosphorylated under both dark and light conditions, belonged to
the same population or to different ones.
Similar results were observed with the phospho-Ser110 antibody
(figure 7 G-L). Again, there was substantially more Ser110 phosphorylation on
the giant plaques in dark conditions than in the light. The small to medium sized
Cx35 gap junctions showed variable levels of phosphorylation in both light and
dark conditions, with some gap junctions showing no phosphorylation (arrow).
To determine if the changes in Cx35 phosphorylation that were
observed empirically represent consistent changes we performed quantitative
analysis of the phospho-specific antibody labeling on giant Cx35 plaques in the
inner plexiform layer. The large size of these giant plaques relative to others in
the hybrid bass retina, their typical oblong shape, and their unique distribution
were used to segregate them from the total population of plaques for analysis.
Figure 8A shows a histogram of the distribution of Cx35 plaques by size in the
inner plexiform layer. Plaque abundance decreased steadily with increasing area,
and the vast majority of plaques were included in bins containing areas less than
2.5 μm2. The number of plaques per bin became relatively stable in bins
containing areas greater than 4.9 μm2, and this was chosen as the cutoff point to
segregate giant plaques from the total population. Visual inspection of the image
data confirmed that all plaques above the cutoff point were of the characteristic
size, shape, and distribution described above. Phospho-specific antibody labeling
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Figure 7. Cx35 phosphorylation varies across gap junction type and with
light-adaptation state.
All images are from sublamina b of the inner plexiform layer of hybrid bass
retina. A-C. Double labeling for phospho-Ser276 (A) and monoclonal anti-Cx35
(B) in dark-adapted retina. Scale bar is 5 μm; scale is the same for each image.
C. Merged image of A and B. Many Cx35 plaques were strongly labeled by the
phospho-Ser276 antibody in dark-adapted retina, including the giant plaques
described (triple arrowhead), while other plaques were devoid of labeling (arrow).
D-F. Double labeling for phospho-Ser276 (D) and monoclonal anti-Cx35 (E) in
light-adapted retina. F. Merged image of D and E. Phospho-Ser276 antibody
labeling was markedly reduced on Cx35 giant plaques in light-adapted retina
(triple arrowhead), and again some plaques showed no labeling at all (arrow). A
population of medium-sized plaques continued to show strong labeling in lightadapted retina (single arrowheads). G-I. Double labeling for phospho-Ser110 (G)
and monoclonal anti-Cx35 (H) in dark-adapted retina. I. Merged image of G and
H. Numerous Cx35 plaques were labeled by the phospho-Ser110 antibody in
dark-adapted retina, including strong labeling on the giant plaques. J-L. Double
labeling for phospho-Ser110 (J) and monoclonal anti-Cx35 (K) in light-adapted
retina. L. Merged image of J and K. Phospho-Ser110 labeling was reduced on
Cx35 giant plaques in light-adapted retina. Labeling on other plaques was
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variable, with most Cx35 gap junctions showing some labeling. However, a few
showed no labeling (arrow). The descending process of a Müller cell nonspecifically labeled by the phospho-Ser110 antibody can be seen on the right side
of the image.
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normalized to the monoclonal Cx35 antibody labeling was calculated for each
plaque in 3-6 images per animal (see methods). Figure 8B shows the effect of
background illumination on Cx35 phosphorylation at Ser110 and Ser276 (n = 3
animals per condition). Giant plaques (figure 8B, right two pairs) showed
significantly less phosphorylation at Ser110 and Ser276 in light-adapted retina
(unpaired t-test, p < 0.05 for each). The remaining smaller plaques (figure 8B,
left two pairs) did not show any significant difference in phosphorylation at either
Ser110 or Ser276 between dark- and light-adapted retinas.
In the outer plexiform layer, where Cx35 is present in both cone and
bipolar cell gap junctions (O'Brien et al., 2004), the phospho-Ser276 antibody
labeled several morphologically distinct populations of Cx35 gap junctions
(figure 9). Large plaques that varied from round to ellipsoid (arrows), and which
may represent bipolar cell gap junctions, showed strong phospho-Ser276 labeling
in both dark- and light-adapted retina. Narrow, string-like gap junctions (double
arrowheads), which likely represent those found on cone telodendria (O'Brien et
al., 2004), were also well-labeled by the phospho-Ser276 antibody in both
conditions. Small, round plaques (arrowheads) showed lesser phospho-Ser276
labeling than the other two populations in the dark-adapted retina and almost no
labeling in the light-adapted retina.
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Figure 8. Quantitative analysis of phosphorylation on Cx35 plaques in the
inner plexiform layer.
A. Histogram of Cx35 plaque size in the IPL. The arrow indicates the
empirically determined cutoff point used to distinguish the giant plaques
distributed in two symmetric bands in the IPL from the total population of Cx35
plaques (see methods). Each bin is 250 pixels (~1.225 μm2). For visual clarity,
only every other bin is labeled on the x-axis. Note that scaling on the y-axis
switches to logarithmic after the break. Data from six animals are shown (3-6
images per animal). B. Effects of background illumination on Cx35 gap junction
phosphorylation. Giant plaques (right two pairs) exhibited significantly less
phosphorylation at both Ser110 and Ser276 in light-adapted retina than in darkadapted retina. The remaining smaller plaques (left two pairs) did not show a
significant difference in phosphorylation at Ser110 or Ser276 between dark- and
light-adapted retina. n = 3 animals per condition. * designates significance at p <
0.05 level.
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Figure 9. Phosphorylated Cx35 in the outer plexiform layer.
A-C. Double labeling for phospho-Ser276 (A) and monoclonal anti-Cx35 (B) in
dark-adapted OPL. Scale bar is 5 μm; scale is the same for each image. C.
Merged image of A and B. Large, round-ellipsoid (arrows) and string-like (double
arrowheads) Cx35 plaques were well-labeled by phospho-Ser276 in dark-adapted
OPL. Small, round plaques (arrowheads) showed lesser labeling. D-F. Double
labeling for phospho-Ser276 (D) and monoclonal anti-Cx35 (E) in light-adapted
OPL. F. Merged image of D and E. Phospho-Ser276 antibody labeling on lightadapted OPL was similar to dark-adapted OPL for large, round-ellipsoid (arrows)
and string-like (double arrowheads) Cx35 plaques, while small round plaques
(arrowheads) showed almost no labeling.
“
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Zebrafish are rapidly emerging as a prominent model system for studies of
the retina and of disease (Fadool and Dowling, 2007; Lieschke and Currie, 2007).
The phospho-specific Cx35 antibodies also label Cx35 gap junctions in zebrafish in
confocal light microscopy and in immuno-electron microscopy (Li et al., 2009); John
Rash, personal communication). Using these tools we found also found lightdependent changes in the phosphorylation of Cx35 plaques in zebrafish. Exposing
dark-adapted zebrafish eyecups to 15 minutes of photopic light triggered decreases in
the phosphorylation of a subpopulation of large gap junction plaques at both Ser110
and Ser276 (figure 10). Although smaller in absolute size than the very large plaques
in hybrid bass, these gap junctions are similar in all aspects to those in hybrid bass:
their large size relative to other Cx35 gap junctions, characteristic oblong
morphology, and distribution in sublamina 1 and at the border of sublaminae 4 and 5
in the inner plexiform layer (IPL), and are likely to mediate coupling between the
same cell type in zebrafish as the giant plaques do in hybrid bass.
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Figure 10. Modulation of Cx35 phosphorylation by acute light exposure in
zebrafish retina.
A & C, In dark adapted zebrafish retina, phosphorylation is strong at both Ser110 and
Ser276 on the population of largest-sized Cx35 plaques. B & D, 15 minutes of photopic
light exposure reduced phosphorylation at both Ser110 and Ser276 on the population of
largest-sized Cx35 plaques. E, Effects of 15 minutes of photopic light exposure on Cx35
gap junction phosphorylation in nightime, dark-adapted zebrafish eyecups.
Phosphorylation on the population of largest-sized Cx35 plaques (right two pairs),
resembling the “giant” plaques of hybrid bass retina, was significantly reduced at both
Ser110 and Ser276 by the exposure to bright light. The remaining smaller plaques (left
two pairs) did not show a significant difference in phosphorylation at Ser110 or Ser276
across conditions. The pattern of change in mean phosphorylation in all groups strongly
resembles the pattern obtained when comparing dark-adapted and light-adapted hybrid
bass retina. n = 5 animals per condition. * designates significance at p < 0.05 level, **
designates significance at p < 0.01 level.
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“

Discussion
The regulation of coupling through Cx35/36 gap junctions by
phosphorylation has now been well described. (Mitropoulou and Bruzzone, 2003)
found that a consensus PKA recognition sequence in the intracellular loop of
perch Cx35 was essential for the 8-Br-cAMP-induced reduction in hemichannel
currents observed in Xenopus oocytes. They further found that re-creating this
recognition sequence in skate Cx35, which was unresponsive to 8-Br-cAMP in its
wild-type form in Xenopus oocytes, conferred the same behavior to this connexin.
This strongly suggested that phosphorylation regulates current flow through
Cx35. We subsequently showed that phosphorylation by PKA at Ser110, the
target of this PKA recognition sequence, was responsible for reduction of tracer
coupling in perch Cx35 expressed in HeLa cells. However, full regulation
required concomitant phosphorylation at a second site, Ser276, in addition to
Ser110 (Ouyang et al., 2005). Phosphorylation at either site alone caused only a
small degree of uncoupling: a 20% reduction in diffusion coefficient in mutants
lacking one phosphorylation site compared to a 56% reduction in diffusion
coefficient in the wild-type.
PKA phosphorylation at the homologous sites has been confirmed for
mouse Cx36 and parallel regulation by PKA phosphorylation has been proposed
(Urschel et al., 2006), although direct regulation by phosphorylation was not
tested. Nonetheless, the high degree of sequence homology between these
connexin gene homologues suggests that the mammalian Cx36 is regulated in the
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same fashion as fish Cx35. Our finding that both mouse and rabbit Cx36 were
phosphorylated at both Ser110 and Ser293 (homologous to Ser276 in fish Cx35)
in the retina supports this contention.
It is not yet clear how phosphorylation regulates coupling in Cx35/36
gap junctions. Phosphorylation could have a direct effect on channel properties of
Cx35/36 gap junctions, as has been seen for a number of other connexin channels.
For example, Cx43 channels expressed in SkHep1 cells show a reversible shift
from a 90-100 pS main state to a 60-70 pS subconductance state with activation of
PKC (Moreno et al., 1994; Kwak et al., 1995). These effects are mediated by
phosphorylation of Ser368 by PKC (Lampe et al., 2000). Macroscopic coupling
through Cx45 was also found to be influenced by phosphorylating conditions:
PKC phosphorylation increased conductance, while PKA or tyrosine
phosphorylation decreased conductance (van Veen et al., 2000). However, in this
case subconductance states were not observed to change; changes in the open
probability of the channels were responsible for the changes in macroscopic
conductance. Thus phosphorylation can affect several important characteristics of
gap junction channels that influence functional coupling.
Phosphorylation may also affect assembly or disassembly of gap
junctions. Treatment with phorbol esters increased Cx43 phosphorylation and
inhibited assembly of plasma membrane Cx43 into gap junctions in Novikoff
hepatoma cells (Lampe, 1994). This treatment did not appear to influence
stability of pre-existing gap junctions. In lens fiber cells, Cx50 and Cx46 were
phosphorylated and gap junctions partially disassembled by similar phorbol ester
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treatments (Zampighi et al., 2005). Such treatments also resulted in a substantial
decrease in dye coupling, although it is not clear whether the reduction in dye
coupling is a result of gap junction disassembly or changes in channel properties.
Studies of Cx36 have revealed that mutation of the major consensus
phosphorylation sites did not affect trafficking of Cx36 to the plasma membrane
or the formation of gap junctions (Zoidl et al., 2002). The latter suggests that
regulation of Cx35/36 by phosphorylation on the identified regulatory sites is
more likely due to modification of channel properties than of gap junction
assembly.
The requirement for phosphorylation of two separate sites to regulate
Cx35/36-mediated coupling imparts significant flexibility. First, these two
phosphorylation sites have substantially different sequences that may have
different affinities for PKA or the phosphatases that de-phosphorylate them. One
of the sites, Ser276, is also known to overlap with a calmodulin binding site (Burr
et al., 2005). Hence the sites can be considered independent. Second, the two
identified regulatory phosphorylation sites appear to be targets for a number of
signaling pathways in addition to the cAMP/PKA pathway. We have found that
PKG also phosphorylates both of these sites in vitro (Patel et al., 2006). These
sites are also consensus phosphorylation sequences for Casein Kinase II, Ca2+Calmodulin-dependent kinases, and S6 Kinase II (summarized in figure 1; see
also (Sohl et al., 1998; Urschel et al., 2006). Not all of these kinases are predicted
to phosphorylate both sites, which emphasizes that the sites are not equivalent. It
is possible to construct a number of regulatory schemes that rely on two or more
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independent signaling pathways to control the coupling through Cx35/36 gap
junctions. Two such pathways, the dopamine pathway routed through cAMP and
the nitric oxide pathway routed through cGMP, are both important in light
adaptation and known to influence gap junction coupling.
One significant prediction of the requirement for phosphorylation at
two sites to regulate coupling is that gap junctions in different cell types could be
regulated in different ways. Our phosphorylation data provide evidence that this
is the case in the fish retina. The giant Cx35 gap junctions in the IPL showed
prominent shifts in phosphorylation state at both Ser110 and Ser276 sites between
dark-adapted and light-adapted conditions. Our model predicts that the weakly
phosphorylated state of these gap junctions in the light would correlate with
strong coupling, while the heavily phosphorylated gap junctions in the darkadapted state would support reduced coupling. However, the changes in
phosphorylation state seen in the very large gap junctions were clearly not global.
Many medium sized Cx35 gap junctions in the vicinity of these large plaques
were well phosphorylated under both dark- and light-adapted conditions, and a
few were virtually non-phosphorylated under both conditions. Since we could not
identify the cell types in which these gap junctions reside, we could not determine
if they represent relatively invariant gap junctions or rather a shift in
phosphorylation status between light- and dark-adapted states in particular cell
populations. In either case, the presence of strongly and weakly phosphorylated
gap junctions in close proximity indicates that the phosphorylation state of the gap
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junction is under local control. This implies that adjacent neural circuits regulate
their coupled states independently, even though they use the same connexin.
The abundant Cx35 gap junctions in fish retina belong to many cell
types. Although we have found them to be present in cone photoreceptor and
Mb1 bipolar cell gap junctions, the majority are likely to be in amacrine cells, as
revealed by in situ hybridization labeling of many cell types in the proximal inner
nuclear layer (O'Brien et al., 2004). Tracer coupling and the ultrastructural
presence of gap junctions has been described in several types of amacrine cells in
the fish retina (Teranishi et al., 1984; Marc et al., 1988; Hidaka et al., 1993;
Teranishi and Negishi, 1994; Hidaka et al., 2005). These gap junctions allow
expansion of receptive fields beyond the dendritic spread, spike synchronization,
and summation of responses (Hidaka et al., 1993; Hidaka et al., 2005). In
mammalian AII amacrine cells, homologous coupling provides for summation of
rod signals, in part setting the sensitivity of the rod pathway. Regulation of
coupling preserves the fidelity of rod signaling through the broad scotopic
operating range (Bloomfield and Volgyi, 2004). Unlike the very well studied
mammalian AII amacrine cell, very little has been reported regarding changes in
fish amacrine cell receptive fields in response to light adaptation.
The striking change in phosphorylation of Cx35 in the giant gap
junctions with light adaptation suggests that the cell type harboring these gap
junctions re-configures its receptive field during adaptation. Based upon the
previous results reported in cell culture systems (Ouyang et al., 2005), we predict
that the decrease in phosphorylation at both Ser110 and Ser276 on giant gap
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junctions in light-adapted retina will result in increased coupling, which in turn
may influence receptive field size and signaling range in the cell type harboring
them. Note that this change in coupling in response to light-adaptation would be
opposite to that which is observed in the AII amacrine cell (Bloomfield and Xin,
1997). Dopamine signaling is known to increase in light-adapted retina (Kramer,
1971; Iuvone et al., 1978; Dearry and Burnside, 1986) and to cause uncoupling in
the AII amacrine cell via D1-type receptors (Hampson et al., 1992). If dopamine
also influences the phosphorylation of the Cx35 giant gap junctions we predict
that it would do so via D2/D4-type dopamine receptors, such as those found in
photoreceptors (Cohen et al., 1992) and dopaminergic interplexiform cells
(Harsanyi and Mangel, 1992) and which cause a decrease in cAMP signaling
through a gi protein. The nitric oxide/cGMP/PKG pathway has also been shown
to affect Cx35 phosphorylation, and several other signaling pathways are
predicted to (Patel et al., 2006). This raises the possibility that phosphorylation of
the giant gap junctions is influenced by transmitters other than dopamine. In the
absence of physiological data we cannot at present speculate further about the
consequences of decreased phosphorylation on giant Cx35 gap junctions in hybrid
bass, but presumably such a change would contribute to optimization of signal
processing during light adaptation.
“

The modulation of Cx35 phosphorylation in hybrid bass relative to light
adaptation state could be controlled by light-stimulated changes in cell signaling, but
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circadian control of phosphorylation cannot be ruled out in these experiments since the
dark-adapted and light-adapted eyes were collected at different points in the light cycle.
However, the finding that acute light exposure modulates phosphorylation of Cx35 in
zebrafish provides evidence that regulation of Cx35 by light is controlled, at least in part,
by light-stimulated changes in cell signaling. Circadian control may also exist, though
future experiments must be done to determine this.
Previous research in several fish species has identified a cell type that is likely
to harbor the large or “giant” Cx35 gap junctions that we found in zebrafish and hybrid
bass. In an ultrastructural study of the goldfish retina very large gap junction plaques
(similar in size to the large plaques in the hybrid bass IPL) were identified in largecaliber amacrine cell dendrites that stratified in sublayer 1 of the IPL (Marc et al., 1988).
The cell containing these very large gap junction plaques was inferred to make
homologous gap junctions with neighboring cells and to possess transient ON-OFF light
responses based on its similarity to a cell in the retinas of carp and roach fish (Djamgoz et
al., 1990; Negishi and Teranishi, 1990; Cook and Becker, 1995). The morphology of this
cell type has been documented in several fish species (carp, roach, and Japanese dace); it
has a fusiform soma located in the inner nuclear layer (INL) immediately adjacent to the
IPL (but is also sometimes reported as being interstitial and located in sublayer 1 of the
IPL), is bistratified, and makes gap junctions at tip-tip or tip-shank contacts with
neighboring cells of the same type (Wagner and Wagner, 1988; Djamgoz et al., 1989;
Hidaka et al., 2005). This cell’s gap junctions are organized into very large plaques that
pass neurobiotin but do not pass Lucifer yellow (Hidaka et al., 2005), a characteristic of
Cx35/36 gap junctions (Hampson et al., 1992). These studies suggest that the cell type
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harboring the large or “giant” Cx35 gap junctions is common to all teleost fish species,
and likely shows modulation of Cx35 phosphorylation by light in the same direction as
we observed in hybrid bass and zebrafish.

“
The diversity of neurotransmitter receptors and signaling pathways in
retinal neurons allows for vastly different but finely-tuned responses specific to
individual cell types. Cx35 gap junctions are a key component of some neural
circuits and have the potential to remodel circuit properties in response to
signaling. The convergence of multiple signaling pathways at regulatory
phosphorylation sites on Cx35 (see figure 1) implies that the coupling state of
Cx35-expressing cells can be controlled with a high degree of precision, and our
results suggest that this happens at a very local level in retinal neurons.
“

Our results also highlight the need for readily identifiable retinal neuron
networks in future studies of the signaling mechanisms regulating Cx35/36 gap junctions.
The large number of inner retinal networks that express this protein threaten to “drown
out” signaling effects that preferentially modulate phosphorylation of Cx35/36 in only
one or two cell types. In this study we were able to bypass this difficulty due to the
unique characteristics of the giant gap junctions. Future studies may have similar success
by utilizing genetically-altered mice which express GFP in individual retinal neurons
(Siegert et al., 2009) that express Cx36, or by utilizing cells types which can be readily
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and diffusely immunolabeled, such as the mammalian AII amacrine cell (Massey and
Mills, 1999). The AII amacrine cell is a particularly promising target for such studies as
it is already known that dopamine signaling modulates the coupling state of the AII
network (Hampson et al., 1992).

59

Chapter 3

Dopamine-stimulated dephosphorylation of connexin 36 mediates AII
amacrine cell uncoupling

The quoted material in this chapter was previously published as:

“Dopamine-stimulated dephosphorylation of connexin 36 mediates AII amacrine cell
uncoupling”
in
The Journal of Neuroscience, November 25, 2009, 29(47):14903-14911.
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“
Introduction
Electrical synapses formed by gap junctions between neurons underlie
a number of important neural functions, including neuronal synchronization
(Deans et al., 2001), signal averaging (DeVries et al., 2002), and network
oscillations (Hormuzdi et al., 2001; Buhl et al., 2003), in addition to providing an
alternative form of synaptic connection with properties that differ distinctly from
the more common chemical synapses. Connexin 36 (Cx36) is the most widely
expressed gap junction protein in neurons (Connors, 2009), but little is known
about how intercellular coupling mediated by Cx36 is regulated. Loss of Cx36
eliminates electrical coupling and coordinated output in certain cortical
interneurons (Deans et al., 2001), impairs gamma frequency oscillations in
hippocampus (Hormuzdi et al., 2001; Buhl et al., 2003), causes deficits in
cerebellar motor learning (Van Der Giessen et al., 2008), and eliminates the highgain rod photoreceptor pathway (Guldenagel et al., 2001; Deans et al., 2002;
Volgyi et al., 2004). Cx36 is also the dominant connexin in pancreatic beta cells
(Serre-Beinier et al., 2008), and loss of these gap junctions causes insulin
secretion abnormalities that resemble those observed in type 2 diabetes
(Wellershaus et al., 2008). Thus, understanding the regulation of Cx36 channel
function is of critical importance to understanding brain and sensory system
function as well as endocrine function.
The retina is an ideal tissue for studying regulation of gap junctionmediated coupling; every class of retinal neuron expresses gap junction proteins
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(Bloomfield and Volgyi, 2009), and the tissue remains physiologically intact
when isolated from the eye. In mammalian retina the AII amacrine cell, which
receives input from rod bipolar cells (Strettoi et al., 1990) and is critical for rodmediated vision (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et al., 2004),
is a well-established model for studying Cx36-mediated coupling (Famiglietti and
Kolb, 1975; Mills and Massey, 1995; Feigenspan et al., 2001a; Mills et al., 2001b;
Veruki and Hartveit, 2002a; Xia and Mills, 2004; Veruki et al., 2008). AII
amacrine cells are extensively coupled to each other by Cx36 gap junctions under
scotopic background light and are uncoupled in response to photopic background
light (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004), dopamine D1-like
receptor (D1R) activation (Hampson et al., 1992), and protein kinase A (PKA)
activation (Mills and Massey, 1995; Urschel et al., 2006). Studies in cell cultures
have identified two phosphorylation sites on the fish homologue of Cx36, Ser110
and Ser276 (Ser293 in mammals), that are required for regulation of Cx36mediated coupling by PKA (Ouyang et al., 2005). These sites have been shown
to undergo dynamic changes in phosphorylation state in the retina (Kothmann et
al., 2007). We therefore sought to determine the relationship between Cx36
phosphorylation and regulation of Cx36-mediated coupling by utilizing the welldescribed AII amacrine cell system.
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Methods
Intracellular injection
Care and use of experimental animals was performed in accordance
with institutional guidelines at the University of Texas Health Science Center at
Houston. All experiments were performed on light-adapted animals in the
daytime phase of their light cycle. Adult rabbits were anesthetized with urethane
(1.5 g/kg, i.p.), and the eyes removed into Ames medium bubbled with 95%
O2/5% CO2. Following this, the animals were killed by intracardial injection with
an overdose of urethane. The superior portion of the retina was separated into
several retina-sclera pieces, which were then incubated with DAPI (4,6-diamino2-phenylindole; Molecular Probes; Eugene, OR) for 20 minutes to label cell
nuclei (this short incubation labels AII amacrine cells preferentially (Mills and
Massey, 1991)). Immediately before each piece was to be injected, the retina was
isolated and mounted photoreceptor-side down on black nitrocellulose filters.
Neurobiotin (3.5%; Vector Laboratories; Burlingame, CA) was injected by
iontophoresis (±1 nA, 3 Hz) into AII amacrine cells, as described previously in
detail (Xia and Mills, 2004), except that Alexa 488-conjugated biocytin
(Molecular Probes) was used to visualize the microelectrode. Injections were
performed for 5 minutes on an Olympus BX51WI microscope; this was followed
by a 15 minute diffusion period. Each piece was superfused, starting 15 minutes
prior to the start of the injection and on through the diffusion period, with either
bubbled Ames medium (at 35°C) or Ames medium containing D1R agonist
(SKF38393, 10 or 100 μM) or antagonist (SCH23390, 10 or 100 μM). After

63

tracer injection and diffusion periods, the pieces of retina were fixed for 15
minutes in 4% formaldehyde in 0.1 M phosphate buffer, and subsequently
immunolabeled for Cx36 and phospho-Ser293-Cx36 (Kothmann et al., 2007).
Dopaminergic drugs were purchased from Tocris (Ellisville, MO).

Pharmacology experiments
Rabbit eyecups with the vitreous removed were separated into superior
and inferior portions by chopping along the myelinated band with a razor blade.
The central portion of the superior part from a single eye was then further
separated into 4 adjacent retina-sclera pieces. Each retina-sclera piece was
incubated for 20 minutes in bubbled Ames medium (at 35°C) with the appropriate
pharmacologic agent. Thus, each experiment yielded one control piece and three
matched pieces subjected to various pharmacological treatments. Following the
incubation period, the retina-sclera pieces were fixed for 15 minutes in 4%
formaldehyde in 0.1 M phosphate buffer, after which the retina was isolated,
mounted photoreceptor-side down on nitrocellulose filters, and immunolabeled
for Cx36 and phospho-Ser293-Cx36. The cAMP analogs were purchased from
Axxora (San Diego, CA) the microcystin-LR from Calbiochem (San Diego, CA),
and the tautomycetin from Tocris.

Immunolabeling
Isolated retina pieces (photoreceptor-side down on nitrocellulose
filters) were first blocked overnight at 10°C in immunolabeling buffer (phosphate
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buffered saline with 0.5% Triton X-100, 0.1% NaN3, pH 7.4) with 10% normal
donkey serum (Jackson Immunoresearch; West Valley, PA). Pieces were then
labeled with monoclonal mouse anti-Cx36 (mCx36, 1:1,000 dilution; Chemicon;
Temecula, CA) and rabbit anti-phospho-Ser293-Cx36 (Ser293-P, 1:1,000
dilution) (Kothmann et al., 2007) antibodies in immunolabeling buffer with 10%
donkey serum for 5 days at 10°C. Retina pieces from pharmacology experiments
were also labeled with goat anti-calretinin antibodies (1:5,000 dilution;
Chemicon) to label AII amacrine cells. After extensive washing, retina pieces
were labeled with secondary antibodies (1:500 dilutions) in immunolabeling
buffer with 5% donkey serum overnight at 10°C. For retina pieces from injection
experiments, anti-calretinin labeling was replaced with Alexa 488-conjugated
streptavidin (1:250 dilution) to label Neurobiotin in the injected network. Alexa
488-conjugated streptavidin and secondary antibodies were purchased from
Molecular Probes. All other secondary antibodies were Cy3- or Cy5-conjugated
(Jackson). Retina pieces were whole-mounted on slides with Vectashield
(Vector).

Imaging and data quantification
Images were collected on a Zeiss LSM 510 Meta confocal microscope
using a 63x (1.4 N.A.) or 40x (1.3 N.A.) oil immersion objectives. Imaging
settings in the LSM software were identical where comparisons are made.
Coupling between AII amacrine cells was quantified as the diffusion coefficient
for Neurobiotin tracer transfer using a 2-dimensional compartmental diffusion

65

model (Xia and Mills, 2004). Cx36 phosphorylation was quantified as the ratio of
the mean intensity of Ser293-P to mCx36 immunofluorescence at individual
regions of interest (ROIs), each identified by the mCx36 label as a single Cx36
gap junction plaque. ROI identification was accomplished using SimplePCI
software (Compix; Sewickley, PA) to analyze single optical sections. ROI
borders were defined by a 20% intensity threshold in the mCx36 channel and a
size threshold of 0.15 μm2. For the pharmacology experiments, an additional,
empirically determined intensity threshold was added in the calretinin channel to
include only the Cx36 gap junctions localized on the AII network. In our hands,
this represents 96% of the Cx36 gap junctions in stratum 5 of the rabbit inner
plexiform layer, in good agreement with a previously reported value of 98%
(Mills et al., 2001b). In the case of injected AII networks, single optical sections
were collected focused on the distal dendrites of the injected cell, and all gap
junctions in the field of view were included. Since 96-98% of the gap junctions at
this focus depth in the retina are on AIIs, even when Neurobiotin diffusion was
weak there was a very low probability of including Cx36 plaques that were not on
AII amacrine cells.
In the pharmacology experiments, six images were collected at midperipheral eccentricity from each condition; in the injection experiments, three
images were collected on different sides of each injected cell. The ratio of the
mean intensity of Ser293-P to mCx36 immunofluorescence was calculated for
each ROI and averaged across all ROIs in all images per condition. In this way,
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we collapsed the phosphorylation data into one value per condition per animal in
order to perform statistical analysis.
In order to calculate the fraction of Cx36 plaques that showed any
detectable phospho-Ser293 antibody labeling, regardless of its intensity, we first
measured the background labeling in the Ser293-P channel for all images
(measured in areas where no mCx36 labeling existed). We then set a threshold
for detectable labeling at 200% of the mean background value (this value
approximated the mean + 2 s.d. of the background levels observed in the initial
experiments). Any Cx36 gap junction plaque with Ser293-P labeling above this
threshold was considered “detectably phosphorylated” for purposes of calculating
the fraction of plaques showing phosphorylation.
Images presented in the figures were collected using identical settings
in the LSM software. Processing was limited to application of a 10% intensity
threshold in all channels to minimize background noise.

Statistical analysis
A linear regression was used to find the correlation between relative
Cx36 phosphorylation and AII amacrine cell coupling. Unpaired, two-tailed ttests were used to compare each drug-treated condition with the control condition
from the same animal. Unpaired, two-tailed t-tests were also used to compare two
drug-treated conditions that shared one common drug (such as D1R agonist
condition vs. D1R agonist plus phosphatase inhibitor).
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Results
AII amacrine cell uncoupling is associated with dephosphorylation of Cx36
We combined intracellular injection of the Cx36-permeant tracer
Neurobiotin with immunolabeling for phospho-Ser293-Cx36 in order to measure
AII amacrine cell coupling and Cx36 phosphorylation in isolated rabbit retina. As
previously reported (Hampson et al., 1992), AII-AII coupling was modulated by
dopamine signaling (Fig.1, A-C). Activation of D1Rs (SKF38393, 10 μM)
reduced AII-AII coupling (Fig. 1B), while antagonism of D1Rs (SCH23390, 100
μM) increased coupling (Fig. 1C). Phosphorylation of Cx36 at Ser293 (Ser293-P)
was assessed at gap junctions on the injected AII amacrine cell dendrites and
those nearby (Fig. 1, D-F; see Methods). Ser293-P was decreased by D1R
activation (Fig. 1H) relative to control (Fig. 1G). Consistent with this, D1R
antagonism increased Ser293-P (Fig. 1I). In order to quantify AII amacrine cell
coupling, we used a compartmental diffusion model to estimate the diffusion
coefficient of the Neurobiotin tracer (Xia and Mills, 2004). We quantified
Ser293-P as a ratio of the mean fluorescence intensity of the phospho-Ser293Cx36 antibody to the mean fluorescence intensity of a monoclonal Cx36 antibody
at each individual gap junction plaque (for full details see Methods section). We
collected three images focused on the dendrites of each injected AII amacrine
cell, calculated the mean Ser293-P for all Cx36 plaques detected across all three
images, and plotted this against the diffusion coefficient for Neurobiotin tracer
transfer measured for that AII amacrine network (Fig. 1J). A strong correlation
(r2 = 0.86) was found between AII amacrine cell coupling and Cx36
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Figure 1 | AII amacrine cell coupling is directly related to Cx36
phosphorylation at Ser293. A-C, Neurobiotin tracer coupling between AII
amacrine cells is modulated by dopamine D1R signaling. D1R activation (B,
SKF38393, 10 μM) reduced the extent of Neurobiotin diffusion relative to control
(A). D1R antagonism (C, SCH23390, 100 μM) increased tracer diffusion.
Images are mini-stacks (2 μm in z-depth) focused on the somas of the AII
amacrine cells. Yellow boxes highlight areas shown in D-I (at different focal
depth). D-F, Cx36 gap junctions, labeled with mCx36 antibody (red) and
Ser293-P antibody (green), on and around the dendrites of the injected AII
amacrine cell, labeled with fluorophore-conjugated Streptavidin (blue). The Cx36
gap junctions not on the injected cell are primarily on other AII amacrine cells
(see Methods). Arrowheads identify prominent Cx36 gap junctions on the
injected cells. G-I, Phosphorylation of Cx36 at Ser293, a site known to regulate
coupling through Cx36 gap junctions (Ouyang et al., 2005), is also modulated by
dopamine D1R signaling. Arrowheads identify the locations of the same Cx36
gap junctions identified in D-F. D1R activation (H, SKF38393, 10 μM) reduced
Ser293-P labeling relative to control (G). D1R antagonism (I, SCH23390, 100
μM) increased Ser293-P labeling. J, Quantification of the relationship between
AII amacrine cell coupling and Cx36 phosphorylation at Ser293. The mean ratio
of Ser293-P intensity to mCx36 intensity (across all Cx36 gap junctions in 3
images per injection) is plotted against the diffusion coefficient for Neurobiotin
tracer transfer calculated for each injected AII amacrine cell network. The strong
correlation of the data (r2 = 0.86) indicates a direct relationship between AII
amacrine cell coupling and Cx36 phosphorylation at Ser293. Images are 2 μmdeep stacks. Scale bar in C is 50 μm; bar in F is 5 μm.
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phosphorylation at Ser293. Since Ser293 is known to regulate coupling through
Cx36 gap junctions (Ouyang et al., 2005), this finding leads us to conclude that
phosphorylation at this site increases coupling.

D1R-stimulated dephosphorylation of Cx36 is mediated by PKA
The canonical D1R signaling pathway involves a Gs-protein that
activates adenylyl cyclase, thereby elevating [cAMP]i to activate PKA (Neve et
al., 2004). We therefore examined the role of PKA activity in controlling Cx36
phosphorylation state downstream of D1R signaling using retina-sclera
preparations (Fig. 2; see Methods). D1R activation (SKF38393, 100 μM) caused
a 3.5-fold reduction in Ser293-P intensity (Fig. 2D). Inhibition of PKA (Rp-8CPT-cAMPS, 20 μM) significantly suppressed the effect of D1R activation (Fig.
2F), resulting in intermediate Cx36 phosphorylation that was below control levels
but above the levels seen with D1R activation alone. D1R antagonism
(SCH23390, 100 μM) caused a 2-fold increase in Cx36 phosphorylation (Fig.
2H). As a second measure of the effects of these treatments, we determined if
they altered the fraction of Cx36 plaques that showed detectable Ser293-P
labeling, regardless of fluorescence intensity. Detectable Ser293-P labeling was
defined as 200% of the background fluorescence in that channel (see Methods);
this equated approximately to a 5% threshold in the Ser293-P channel. This
measure yielded results consistent with the mean Ser293-P measurements (Fig.
2J). Histograms of the ratio of Ser293-P to mCx36 fluorescence from one
representative experiment showed that D1R activation caused a leftward-shift
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Figure 2 | PKA mediates D1R-dependent dephosphorylation of Cx36 at
Ser293 in AII amacrine cells. A & B, Under control conditions Ser293-P
(green) labeling of Cx36 gap junctions (mCx36, red) on AII amacrine cells
(calretinin, blue) was heterogeneous. Annotated arrowheads indicate pairs of
Cx36 plaques along single dendrites that are in different phosphorylation states.
The close proximity of Cx36 plaques with widely varying Ser293-P labeling
implies that regulation is locally controlled at individual plaques. C & D, D1R
activation (SKF38393, 100 μM) greatly diminished Ser293-P labeling. E & F,
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) attenuated the dramatic reduction
in Ser293-P labeling caused by SKF38393 (100 μM). G & H, Antagonism of
D1Rs (SCH23390, 100 μM) increased Ser293-P labeling. I, Summary of data
shows that inhibition of PKA significantly suppressed the reduction in Ser293
phosphorylation caused by D1R activation. J, Summary of data shows that
changes in the percentage of Cx36 plaques that show detectable Ser293-P labeling
follows the same pattern established for relative Ser293-P measurements in I.
Error bars are s.e.m, n = 6. Asterisk denotes P < 0.05, two asterisks denote P <
0.01. Images are 1 μm-deep stacks. Scale bar in H is 10 μm.
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Figure S1 | PKA mediates a D1R-stimulated leftward-shift in the relative
phosphorylation of Cx36 at Ser293 in AII amacrine cells. A, Histogram
displaying the distribution of relative Ser293 phosphorylation (ratio of Ser293-P
to mCx36 intensity) on Cx36 plaques under control conditions. Data are from one
representative experiment displayed in Figure 2. B, D1R activation (SKF38393,
100 μM) caused a leftward-shift in the distribution. The majority of Cx36 plaques
showed relatively little or no Ser293 phosphorylation. C, PKA inhibition (Rp-8CPT-cAMPS, 20 μM) blocked the leftward-shift caused by D1R activation
(SKF38393, 100 μM). D, D1R antagonism (SCH23390, 100 μM) caused a
strong rightward-shift in the distribution. Cx36 plaques located in the center of
the distribution (±1 s.d.) showed relatively strong phosphorylation.
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(reduction in Ser293-P) in the population of Cx36 plaques which was blocked by
inhibition of PKA, while D1R antagonism caused a rightward-shift (increase in
Ser293-P) in the Cx36 population (Fig. S1). These results lead us to conclude that
activation of PKA is a component of the pathway regulating Cx36-mediated
coupling of AII amacrine cells. However, these results are not consistent with
direct phosphorylation of Ser293 by PKA, since inhibition of this kinase led to a
net increase in Cx36 phosphorylation.
We also tested the effects of dopamine itself on Cx36 phosphorylation
at Ser293 in AII amacrine cells. Consistent with the effects of D1R agonist,
dopamine application (1 μM) caused a 4-fold reduction in Ser293-P intensity
(control, mean ratio 0.41 ± 0.06 s.e.m.; dopamine, mean ratio 0.096 ± 0.02 s.e.m.;
n = 4, p < 0.01), as well as a similar reduction in the percentage of Cx36 plaques
that showed detectable Ser293-P labeling (control, mean 69 ± 6%; dopamine,
mean 19 ± 8%; n = 4, p < 0.01) (Fig. S2). This concentration of dopamine
represents the upper end of estimates of the physiological extracellular dopamine
concentration in the vertebrate retina (Witkovsky et al., 1993), and is known to
strongly uncouple AII amacrine cells (Hampson et al., 1992; Mills and Massey,
1995). Thus, endogenous levels of dopamine should be sufficient to drive
dephosphorylation of Cx36.
Modulation of Cx36 phosphorylation at Ser293 could alter coupling
between AII amacrine cells in several ways. It could modulate the permeability
of Cx36 gap junctions to the Neurobiotin tracer, stimulate insertion or removal of
gap junction proteins from the plasma membrane at each Cx36 plaque, or cause
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Figure S2 | Exogenous dopamine application causes dephosphorylation of
Cx36 at Ser293 in AII amacrine cells. A, Summary of data shows that
exogenous application of dopamine (1 μM) caused a strong reduction in the
intensity of Ser293-P labeling on Cx36 gap junction plaques. This concentration
of dopamine represents the upper end of estimates of the physiologic extracellular
dopamine concentration in the vertebrate retina (Witkovsky et al., 1993), and is
known to strongly uncouple AII amacrine cells (Hampson et al., 1992; Mills and
Massey, 1995). B, Summary of data shows that changes in the percentage of
Cx36 plaques that show detectable Ser293-P labeling follows the same pattern
established for relative Ser293-P measurements in A. Error bars are s.e.m, n = 4.
Two asterisks denote P < 0.01.
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Figure 3 | Phosphorylation of Ser293 on Cx36 does not alter trafficking or
distribution of the protein. A, Conditions that altered Cx36 phosphorylation
at Ser293 (D1R activation, SKF38393, 100 μM; D1R antagonism, SCH23390,
100 μM) had no effect on the size of Cx36 plaques in AII amacrine cells.
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) also had no effect on Cx36
plaque size. B, Conditions that altered Cx36 phosphorylation at Ser293 (D1R
activation, SKF38393, 100 μM; D1R antagonism, SCH23390, 100 μM) had no
effect on the overall distribution of Cx36 plaques in AII amacrine cells.
Inhibition of PKA (Rp-8-CPT-cAMPS, 20 μM) also had no effect on Cx36
plaque distribution. Error bars are s.e.m, n = 5. No significant changes were
found.
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changes in the number of gap junction plaques between AII amacrine cells.
Changes in Ser293-P caused by D1R receptor activation (SKF38393, 100 μM) or
antagonism (SCH23390, 100 μM) had no effect on the mean plaque size of Cx36
gap junctions or the mean number of plaques on AII dendrites in a given area
(Fig. 3). Thus, the changes in tracer coupling between AII amacrine cells
presented above cannot be attributed to changes in the trafficking of Cx36
proteins or the number of Cx36 gap junctions connecting AII amacrine cells.
Rather, it appears that phosphorylation of Ser293 must modulate the permeability
of Cx36 to the Neurobiotin tracer.

PP2A is required for D1R-stimulated dephosphorylation of Cx36
Because D1R activation reduced Ser293-P, we hypothesized that
dopamine signaling increases overall phosphatase activity at Cx36 gap junctions
in AII amacrine cells. In eukaryotic cells protein phosphatase 1 (PP1) and protein
phosphatase 2A (PP2A) are the most abundant phosphatases (Virshup and
Shenolikar, 2009); thus, we initially targeted these proteins as potential effectors
of D1R-stimulated dephosphorylation of Cx36. We tested the ability of D1R
agonist to reduce Ser293-P in the presence of different phosphatase inhibitors at
concentrations that preferentially inhibit either PP1 or PP2A. Microcystin-LR
(0.5 nM), an inhibitor with higher affinity for PP2A (IC50 = 40 pM) than for PP1
(IC50 = 1.7 nM) (Honkanen et al., 1990), completely blocked the reduction of
Ser293-P caused by D1R activation (SKF38393, 10 μM) (Fig. 4F). Application
of microcystin-LR alone significantly increased Ser293-P levels relative to
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Figure 4 | PP2A is required for D1R-dependent dephosphorylation of Cx36
at Ser293 in AII amacrine cells. A & B, Control; color scheme and antibodies
are the same as Figure 2. C & D, D1R activation (SKF38393, 10 μM) greatly
diminished Ser293-P labeling. E & F, Inhibition of PP2A (microcystin-LR, 0.5
nM) completely blocked the reduction in Ser293 phosphorylation caused by D1R
activation. G & H, Inhibition of PP2A alone led to increased phosphorylation of
Ser293. I, Summary of data shows that inhibition of PP2A significantly blocked
the reduction in Ser293 phosphorylation caused by D1R activation, and that PP2A
inhibition alone significantly increased Ser293 phosphorylation. J, Summary of
data shows that changes in the percentage of Cx36 plaques that show detectable
Ser293-P labeling follows the same pattern established for relative Ser293-P
measurements in I. Error bars are s.e.m, n = 6. Asterisk denotes P < 0.05, two
asterisks denote P < 0.01. Images are 1 μm-deep stacks. Scale bar in H is 10 μm.
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control (Fig. 4H), similar to the effect of D1R antagonist application. Contrasting
these results, tautomycetin (10 nM), an inhibitor with higher affinity for PP1 (IC50
= 1.6 nM) than for PP2A (IC50 = 62 nM) (Mitsuhashi et al., 2001), did not prevent
the D1R-mediated reduction of Ser293-P (Fig. 5F). Interestingly, inhibition of
PP1 with tautomycetin in the absence of D1R activation was sufficient to cause a
robust reduction in Ser293-P (Fig. 5H). As shown in the previous experiments,
the percentage of Cx36 plaques showing detectable Ser293-P labeling followed
the same pattern revealed by measuring the mean Ser293-P for both PP2A and
PP1 inhibitors (Fig. 4J and 5J). These results provide a measure of confidence
that the concentrations of microcystin-LR and tautomycetin used were selective
for PP2A and PP1, respectively, as only microcystin-LR was able to block the
effects of D1R activation, and since they had opposite effects on Cx36
phosphorylation when applied alone. Together, these experiments argue that
PP2A is a necessary component of the D1R pathway regulating Cx36
phosphorylation and coupling strength between AII amacrine cells, and these
results are consistent with direct dephosphorylation of Ser293 by PP2A. These
experiments also provide evidence that PP1 is involved in regulating Cx36mediated coupling of AII amacrine cells. However, these results are not
consistent with PP1 acting directly on Ser293. Rather, they indicate that PP1
negatively regulates the pathway leading to dephosphorylation of Ser293,
although the exact mechanism for this action is unclear.
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Figure 5 | PP1 negatively regulates the dephosphorylation of Cx36. A & B,
Control; color scheme and antibodies are the same as Figure 2. C & D, D1R
activation (SKF38393, 10 μM) greatly diminished Ser293-P labeling. E & F,
Inhibition of PP1 (tautomycetin, 10 nM) did not alter the effects of D1R
activation. G & H, Inhibition of PP1 alone was sufficient to cause a strong
reduction in Ser293-P labeling. I, Summary of data shows that inhibition of PP1
did not prevent the reduction in Ser293 phosphorylation caused by D1R
activation, and that PP1 inhibition alone significantly reduced Ser293
phosphorylation. J, Summary of data shows that changes in the percentage of
Cx36 plaques that show detectable Ser293-P labeling follows the same pattern
established for relative Ser293-P measurements in I. Error bars are s.e.m, n = 4.
Asterisk denotes P < 0.05, two asterisks denote P < 0.01. Images are 1 μm-deep
stacks. Scale bar in H is 10 μm.
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PKA drives PP2A-mediated dephosphorylation of Cx36
Based on the results showing that both PKA and PP2A are
downstream of D1R activation, we next asked if PP2A itself is activated by PKA
in AII amacrine cells. Such a pathway has recently been described in mediumsized, spiny neurons in the striatum, where D1R-stimulated activation of PKA
causes phosphorylation of the regulatory subunit of PP2A and thus increases the
activity of the phosphatase (Ahn et al., 2007). These striatal neurons bear certain
similarities to AII amacrine cells (namely, D1R and DARPP-32 expression)
(Partida et al., 2004; Svenningsson et al., 2004; Witkovsky et al., 2007). In order
to test this hypothesis, we bypassed D1Rs and directly stimulated PKA. PKA
activation (Sp-8-CPT-cAMPS, 20 μM) strongly reduced mean Ser293-P in AII
amacrine cells (Fig. 6D), just as D1R activation did. Inhibition of PP2A
(microcystin-LR, 0.5 nM) completely blocked the PKA-mediated reduction in
Ser293-P (Fig. 6F). Inhibition of PP2A alone caused a trend toward increased
phosphorylation of Ser293-P (Fig. 6I), similar to the to the significant increase
noted above (Fig. 4). As before, the percentage of Cx36 plaques showing
detectable phospho-antibody labeling followed the same pattern established by
measuring the mean Ser293-P intensity (Fig. 6J). These results confirm that
PP2A is required for PKA-dependent dephosphorylation of Cx36 in AII amacrine
cells, and support the existence of the D1R → PKA → PP2A pathway in these
neurons.
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Figure 6 | PP2A is required for PKA-dependent dephosphorylation of Cx36
at Ser293 in AII amacrine cells. A & B, Control; color scheme and antibodies
are the same as Figure 2. C & D, PKA activation (Sp-8-CPT-cAMPS, 20 μM)
greatly diminished Ser293-P labeling, just as D1R activation did. E & F,
Inhibition of PP2A (microcystin-LR, 0.5 nM) completely blocked the reduction in
Ser293 phosphorylation caused by PKA activation. G & H, Inhibition of PP2A
alone slightly increased Ser293 phosphorylation relative to control. I, Summary
of data shows that inhibition of PP2A significantly blocked the reduction in
Ser293 phosphorylation caused by PKA activation. We observed a trend towards
increased Ser293 phosphorylation when PP2A alone was inhibited, similar to the
significant increase we observed previously with the same treatment (Fig. 4). J,
Summary of data shows that changes in the percentage of Cx36 plaques that show
detectable Ser293-P labeling follows the same pattern established for relative
Ser293-P measurements in I. Error bars are s.e.m, n = 5. Two asterisks denote P
< 0.01. Images are 1 μm-deep stacks. Scale bar in H is 10 μm.
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Phosphorylation of Cx36 is controlled independently at each gap junction
plaque
We frequently observed that Cx36 gap junctions in close proximity of
each other existed in very different phosphorylation states, even across gap
junctions positioned along a single dendrite. This was most apparent in control
conditions (Fig. 2A & B, arrowheads; also Fig. S1 D). Pharmacologic activation
of D1Rs reduced the heterogeneity observed in Ser293-P by causing a strong
reduction in the relative degree of phosphorylation at each Cx36 plaque.
Conversely, antagonism of D1Rs led to an increase in the relative degree of
phosphorylation at each Cx36 plaque, indicating that dopamine-driven
dephosphorylation of Cx36 is opposed by an unknown process. Thus, it appears
that our control condition represents a near-equilibrium point, where conditions at
some gap junction plaques favor phosphorylation of Cx36 and conditions at
others favor dephosphorylation of Cx36. The observation that this variation exists
even for pairs of Cx36 plaques within a micron of one another suggests that each
Cx36 gap junction plaque functions as an individual unit, the regulation of which
is at least partially controlled by very local processes.
Overall, we have quantitatively demonstrated the relationship between
AII amacrine cell uncoupling and Cx36 dephosphorylation. Our results describe a
D1R → PKA → PP2A pathway that mediates the dephosphorylation of Cx36 at
Ser293, and thus the D1R-mediated uncoupling of AII amacrine cells (Fig. 7).
PP1 activity negatively regulates this dephosphorylation pathway at an unknown
point. Our results indicate regulation is likely controlled at the level of individual
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Figure 7 | Model of D1R-dependent regulation of Cx36-mediated coupling
between AII amacrine cells. Activation of D1Rs (1) initiates a cascade leading
to activation of PKA (2); both D1R and PKA activation are sufficient to uncouple
AII amacrine cells (Hampson et al., 1992; Mills and Massey, 1995). In this study
we showed that D1R-dependent dephosphorylation (grey P’s) of Ser293 on Cx36
uncouples AII amacrine cells (3). We show that PP2A is required for both D1Rand PKA-stimulated dephosphorylation of Ser293 (4). This provides evidence
that the D1R → PKA → PP2A pathway, which was recently described in spiny
neurons in the striatum and led to dephosphorylation of Thr75 on DARPP-32
(Ahn et al., 2007), is also present in the AII amacrine cell. AII amacrine cells also
express DARPP-32 (Partida et al., 2004; Witkovsky et al., 2007), and
dephosphorylation of Thr75 on DARPP-32 facilitates PKA-mediated
phosphorylation (black P’s) of Thr34 (5), which converts DAPRR-32 into an
inhibitor of PP1 (6) (Svenningsson et al., 2004). We found that PP1 negatively
regulates the dephosphorylation of Cx36, possibly by opposing PKA-mediated
activation of PP2A (7). Our results indicate that the D1R → PKA → PP2A
pathway is not limited to striatal neurons, and may represent a common pathway
in neurons expressing D1Rs and DARPP-32.
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Cx36 plaques, and that phosphorylation of Ser293 appears to influence
permeability of these gap junctions, but not the trafficking of Cx36.

Discussion
One fundamental function of the retina is to adapt to fluctuating
background illumination. Electrical coupling between AII amacrine cells
increases the signal to noise ratio of their response to light (Vardi and Smith,
1996; Dunn et al., 2006). Modulation of coupling strength between AII amacrine
cells serves to optimize signal to noise ratio for prevailing background
illumination, and is one mechanism the retina uses to accomplish luminance
adaptation (Bloomfield and Volgyi, 2004). In darkness AIIs are relatively
uncoupled, thus preserving single-photon responses in a small group of AIIs.
Coupling increases greatly under low scotopic to mesopic illumination, allowing
for summation of coincident signals and improved signal to noise ratio. The AII
network is uncoupled under photopic illumination by dopamine signaling. This
may act to prevent contamination of cone photoreceptor signals in cone bipolar
cells by saturated rod signals in AII amacrine cells. In addition, AIIs provide
inhibitory glycinergic input to Off cone bipolar cells (Strettoi et al., 1992) and
some Off ganglion cells (Manookin et al., 2008; Murphy and Rieke, 2008; Munch
et al., 2009). Thus uncoupling of the AII network should also act to increase the
spatial resolution of On cone bipolar cell-driven feed-forward inhibition of Off
cone bipolar and retinal ganglion cells.
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Previously it was unclear what molecular mechanism modulates
coupling through Cx36 gap junctions. Although increased phosphorylation of
Cx36 has been implicated as a mechanism for uncoupling gap junctions based on
the dependence on PKA activity (Ouyang et al., 2005; Urschel et al., 2006), this
has not been directly assessed. By making quantitative measures of tracer
diffusion between AII amacrine cells and the relative phosphorylation of Cx36
gap junctions between these cells, we have determined that dephosphorylation of
Ser293 is associated with uncoupling of the AII amacrine cell network.
Decreases in both coupling and phosphorylation are triggered by dopamine D1R
signaling and are mediated (at least in part) by activation of PKA. This finding,
together with the previous finding that the Ser293 phosphorylation site is one of
two that are required for regulation of Cx36 coupling by PKA activity (Ouyang et
al., 2005), provides strong evidence that dephosphorylation of Cx36 at Ser293 is
the mechanism by which Cx36 gap junctions are uncoupled.
It has been reported that SCH23390 (10 μM) blocks the uncoupling
effect of exogenous dopamine (100 nM) application (Hampson et al., 1992). It is
thus curious that in our hands 10 μM SCH23390 did not alter AII amacrine cell
coupling, but 100 μM SCH23390 increased coupling. However, technical
differences between our tracer coupling measurements and those made in the
previous study preclude direct comparison. Hampson et al. (1992) used a more
sensitive but nonlinear (peroxidise amplification) tracer detection method and 3 to
4-fold longer diffusion periods, potentially amplifying small effects. It is difficult
to precisely identify the reason that a high concentration of SCH23390 was

85

required to increase coupling in our experiments. It is possible that the nonspecific binding of the drug to other targets with low-affinity binding sites
(Leonard et al., 2006; Ekelund et al., 2007) caused network effects that led to
increased AII amacrine cell coupling. However, given that both the D1R agonist
SKF38393 (10 μM) and dopamine (1 μM) effectively drove reductions in AII
amacrine cell coupling, the specific action of SCH23390 on D1-like dopamine
receptors seems most likely.
The molecular mechanism by which phosphorylation of Ser293 alters
coupling through Cx36 gap junctions is still a topic for further study. We have
excluded changes in the trafficking of Cx36 proteins and reduction in the absolute
number of Cx36 gap junctions on AII amacrine cells as potential mechanisms by
which dephosphorylation of Cx36 reduces coupling. Thus, it seems likely that
dephosphorylation of Cx36 reduces its permeability to the Neurobiotin tracer.
The question of what dephosphorylation of Cx36 does to the single-channel
conductance and/or open probability or open duration of the channel is of more
biological significance in neurons. Although our experiments here cannot directly
address this measure of channel function, it has recently been shown that the
junctional conductance between pairs of AII amacrine cells can change
dynamically up to six-fold (Veruki et al., 2008). This increase was timedependent and was observed with low-resistance patch pipettes, but not with highresistance pipettes, leading the authors to suggest that the increase in coupling
was due to gradual washout of an endogenous regulatory system in the AII
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amacrine cell. Washout of cAMP is the most prominent initial candidate, and
should result in a gradual increase in the phosphorylation of Cx36.
Our results indicate that the D1R- and PKA-dependent
dephosphorylation of Cx36 in AII amacrine cells requires PP2A activation. A
D1R → PKA → PP2A pathway also exists in medium-sized spiny neurons of the
striatum, in which Thr75 of dopamine- and cyclic-AMP-regulated phosphoprotein
(DARPP-32) is one substrate for PP2A (Ahn et al., 2007). This
dephosphorylation allows PKA to phosphorylate Thr34 of DARPP-32, thereby
converting it into a potent inhibitor of PP1 (Svenningsson et al., 2004). DARPP32 is also expressed by AII amacrine cells (Partida et al., 2004; Witkovsky et al.,
2007), and we show that while PP1 inhibition does not mediate D1R-stimulated
dephosphorylation of Cx36, PP1 inhibition alone is sufficient to cause Ser293
dephosphorylation. As PKA activation of PP2A in the striatal spiny neuron was
caused by phosphorylation of the regulatory subunit of PP2A (Ahn et al., 2007),
one explanation for our finding is that PP1 activity may oppose PKA-dependent
activation of PP2A by phosphorylation (Fig. 7), although we did not explicitly test
this hypothesis. It is clear from our results that the dopamine D1R → PKA →
PP2A pathway is not limited to the striatal neurons where it was first described,
but is also a component of dopamine signaling in other neurons, such as the AII
amacrine cell.
In the retina, dopamine signaling originates from dopaminergic
amacrine cells and is associated with light adaptation (Witkovsky, 2004). In
addition to the AII amacrine cell, dopamine modulates the coupling state of other
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Cx36-coupled retinal neurons, such as cone photoreceptors (Lee et al., 2003;
O'Brien et al., 2004; Zhang and Wu, 2004; Ribelayga et al., 2008) and OFF α
ganglion cells (Hidaka et al., 2002; Mills et al., 2007). In both of these cases,
however, activation of D2-like dopamine receptors triggers the uncoupling. This
suggests that in cones and OFF α ganglion cells, reduced [cAMP]i and reduced
PKA activity mediate uncoupling. Based on the relationship between Cx36
phosphorylation and AII amacrine coupling strength that we describe here, we
would predict that in cones and OFF α ganglion cells PKA acts directly on Cx36
proteins, rather than activating a phosphatase effector, and in cones this appears to
be the case (H. Li, A. Chuang, & J.O., 2009; manuscript submitted for
publication). Previous reports support this possibility, as we and others have
shown that PKA can directly phosphorylate regulatory residues on Cx36 in vitro
(Ouyang et al., 2005; Urschel et al., 2006; Kothmann et al., 2007). Thus,
regulation of Cx36-mediated coupling is specific to individual neuronal subtypes
in the retina and is dependent on the signaling pathways they express.
The specificity of regulation that we observe in retinal neurons
indicates that the signaling pathways that control coupling are likely to vary in
other Cx36-coupled networks, such as those found in cortex, hippocampus,
cerebellum and inferior olive, and elsewhere. For instance, several kinases
converge onto the regulatory phosphorylation sites of Cx36 in vitro, including
PKA, PKG, and CamKII (Ouyang et al., 2005; Patel et al., 2006; Urschel et al.,
2006; Kothmann et al., 2007; Alev et al., 2008), suggesting that many common
signaling pathways can modulate coupling. The importance of regulation of

88

Cx36-mediated coupling in other networks is currently not well understood, as
most studies have focused on the consequences of complete loss of Cx36mediated coupling (Deans et al., 2001; Buhl et al., 2003; Van Der Giessen et al.,
2008). The results we present here provide a framework for future study of
coupling in these systems, where increased phosphorylation of Ser293 indicates
increased coupling, and vice versa.
We commonly observed heterogeneity of Cx36 phosphorylation
within individual AII amacrine cells under control conditions. This observation
implies that Cx36 phosphorylation, and thus coupling, is controlled at the level of
individual gap junction plaques. This possibility evokes comparisons to the
postsynaptic density found at chemical synapses, where complexes of signaling
proteins are assembled and provide synapse-specific modulation of important
synaptic elements, such as glutamate receptors (Soderling and Derkach, 2000;
Feng and Zhang, 2009). The C-terminal tail of Cx36 binds PDZ domaincontaining proteins (Li et al., 2004), and may bind some of the same molecules
that form the scaffolding complex at the postsynaptic density. Additionally,
CamKII can bind directly to Cx36 (Alev et al., 2008), providing the means for
localization of one potential regulator of coupling.
Local control of coupling would allow for the possibility of activitydependent regulation of individual electrical synapses. This is particularly
interesting to consider in the case of the AII amacrine cell, which shifts from
uncoupled in dark-adapted retina to well-coupled through most of the scotopic
range of vision, and which finally becomes uncoupled again under photopic visual
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conditions (Bloomfield and Volgyi, 2004) as a result of dopamine signaling.
What causes the increase in coupling when background illumination increases
from darkness to scotopic levels? One possibility is that glutamate release from
rod bipolar cells causes Ca++ influx in the AII dendrites, leading to activation of
CamKII and phosphorylation of Cx36, thus increasing coupling in a manner
dependent on presynaptic activity. There are several potential sources of Ca++ on
AII dendrites, including Ca++-permeable AMPA receptors and NMDA receptors
(Hartveit and Veruki, 1997; Morkve et al., 2002). One possible role for locally
increasing coupling in an activity-dependent manner is to allow the spread and
summation of signals from active rod bipolar cells in AII amacrine cells when
photon catch is very low (near visual threshold). Gap junctions not in the vicinity
of an active rod bipolar cell would remain uncoupled, and thus reduce the sharing
of noisy fluctuations in the AII membrane potential. This could be particularly
important in AIIs, which are inherently noisy due to the nature of the rod bipolar
to AII amacrine synaptic inputs (Dunn et al., 2006). As background light
intensity increases in the scotopic range, additional rod bipolar cells will become
active, and continue to increase AII amacrine cell coupling, as has been described
(Bloomfield and Volgyi, 2004).
“
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Chapter 4

Presynaptic activity and NMDA receptor activation drive
phosphorylation of connexin 36 on AII amacrine cells
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Figures 1-3 in this chapter represent experiments performed by Brady Trexler, Ph.D., a
former postdoc with Steve Massey, Ph.D. (Figures 1 and 3), or by Wei Li, Ph.D., a
former student with Steve Massey, Ph.D. (Figure 2). Their unpublished observations
(represented in these figures) stimulated me to develop and test the hypotheses
concerning the role of NMDA receptors in regulating Cx36 gap junctions on AII
amacrine cells. Thus, I have included them here for logical continuity. I am indebted to
them for their contributions to this research.
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Introduction
One requirement for a well-functioning sensory system is the ability to adapt
to fluctuations in prevailing environmental conditions. For instance, in the course of one
day the retina must maintain its ability to reliably encode the visual environment and
transmit this code to the brain, despite the fact that the mean level of background
luminance will shift over 109-fold from night to day (Rodieck, 1998; Rieke and Rudd,
2009). Adaptation serves to maintain appropriate dynamic range of signaling, preventing
saturation yet preserving discrimination of relevant differences, thus optimizing sensory
system function. A hallmark of luminance adaptation in the retina is modulation of the
strength of electrical coupling between horizontal and amacrine cell interneuron networks
(Bloomfield et al., 1997; Xin and Bloomfield, 1999; Bloomfield and Volgyi, 2004).
Modulation of coupling strength in these networks alters receptive field size, and
consequently changes the spatial extent of feedback and feedforward inhibition. In the
AII amacrine cell interneuron network, electrical coupling also improves the signal-tonoise ratio of the light response (Vardi and Smith, 1996; Dunn et al., 2006).
The AII amacrine cell is an obligatory component of the high-sensitivity rod
photoreceptor pathway (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et al., 2004),
and is extensively coupled to neighboring AIIs by connexin 36 (Cx36) gap junctions
(Kolb and Famiglietti, 1974; Famiglietti and Kolb, 1975; Vaney, 1991; Feigenspan et al.,
2001a; Mills et al., 2001b; Veruki and Hartveit, 2002a). AII amacrine cells display a
complex inverted U-shaped pattern of electrical and tracer coupling modulation relative
to increasing background illumination (Bloomfield et al., 1997; Bloomfield and Volgyi,
2004). In well dark-adapted retina, the AII network is relatively uncoupled. When
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background illumination is increased to just above rod photoreceptor threshold, coupling
increases dramatically, and continues to increase modestly with increasing illumination
through the rod photoreceptor-dominated range of vision. If background illumination is
increased further, into the cone photoreceptor-dominated range of vision, coupling is
driven back down towards baseline levels. This reduction of coupling is thought to occur
through increased dopamine signaling (Hampson et al., 1992; Witkovsky, 2004). Recent
work has demonstrated a direct relationship between the phosphorylation state of Cx36
and tracer coupling in the AII network, and shown that dephosphorylation of the protein
mediates the uncoupling caused by dopamine signaling (Kothmann et al., 2009).
However, the mechanism responsible for increasing coupling in the AII network in the
rod-dominated visual range is still unclear.
The observation that AII amacrine cells increase their coupling once
background illumination exceeds rod photoreceptor threshold, and that coupling
continues to increase with increasing illumination, suggests an activity-dependent process
driven by the ON pathways in retinal circuitry. AII amacrine cells express functional
NMDA receptors (Hartveit and Veruki, 1997; Zhou and Dacheux, 2004), which
commonly mediate activity-dependent changes in postsynaptic neurons. However, to
date no study has described a physiological role for these receptors in the AII. In this
study, we sought to determine if the NMDA receptors expressed by AII amacrine cells
contribute to processes that increase phosphorylation of Cx36 gap junctions, and thus
drive increased coupling in the AII network.
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Methods
Electrophysiology
The inferior portions of rabbit eyecups were cut into strips and attached to
filter paper, vitreal side down. The sclera and choroid were removed and the retinas were
bathed in a modified Ames medium (see below). Retinas were then stored at 10°C for
later recording. Slices were cut on a vertical slicer to varying thickness (120 – 200 μm)
and transferred to the recording chamber. Experiments measuring light responses were
performed on retinas from rabbits that were dark adapted for 2 hrs prior to enucleation;
surgery, isolation of the retina, and preparation of slices were done under dim red light.
A modified Ames solution was used for storing retinas, bath perfusion of
slices, and puffer application of drugs. The salts common to all external solutions
consisted of (in mM) 115 NaCl, 3.1 KCl, 1.24 MgCl2, 2 CaCl2, 0.1 BaCl2, 6 glucose, 2
succinate, 1 malate, and 1 lactate. For the storage solution, 10 mM HEPES, 12 mM
NaHCO3, and 1 mM pyruvate were added and pH was adjusted to 7.4 with NaOH. For
bath perfusion, 24 mM NaHCO3 and 1 mM pyruvate were added and the solution was
bubbled with 95% O2/5% CO2. The perfusate was heated to 37°C with an inline heater
(Warner Instruments, Hamden, CT). Drugs were diluted from stock solutions into the
external solution buffered with 20 mM HEPES, pH = 7.4.
Patch pipette filling solution consisted of (in mM) 110 potassium gluconate,
10 CsCl, 10 NaCl, 10 HEPES, 10 EGTA, 2 MgCl2, 5 K+ATP, 0.5 Na+GTP. The pH was
adjusted to 7.2 with KOH. Lucifer yellow (0.5 mg/ml) or 0.1 mM Alexa-488 (Molecular
Probes, Eugene, OR) were included in the patch solutions to confirm cell identity by
epifluorescent visualization after recording. All chemicals and pharmacological agents
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were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Drug
solutions were delivered by single or triple barrel puffer pipettes. A single barrel would
contain two or more drugs for testing the effects of simultaneous application, rather than
perfusion from multiple barrels.
Patch electrodes were pulled on a Flaming-Brown horizontal puller from
Sutter Instruments (Novato, CA) and fire polished on a Narishige MF-83 microforge
(East Meadow, NY) to a resistance of 7 to 10 MΩ (in KCl pipette solutions, pipette
resistances were 5 to 7 MΩ, due to the higher mobility of chloride relative to gluconate).
Seals in the cell attached configuration ranged from 8 to 20 gigaohms. Upon obtaining a
whole cell patch, series resistance was estimated from the peak of the capacitive
transients due to a square wave voltage pulse and ranged from 20 to 30 MΩ. Series
resistance was not compensated but was monitored periodically by the method of
capacitive transients. Cell currents and voltages were amplified by Axopatch 200 B
patch clamp amplifiers (Axon Instruments, Foster City, CA) in resistive feedback mode.
Current and voltage signals were filtered on [?] the amplifiers at 2 kHz and sampled at 10
kHz using a PCI-MIO16XE-10 data acquisition board from National Instruments (Austin,
TX). Custom software was used for data acquisition and analysis.

Light Stimuli
Light responses were recorded from slices visualized using infrared
photomicroscopy with DIC optics. Light stimuli were delivered to the slice through the
objective from a source consisting of 20 LEDs (525 nm peak, ±17 nm at half-width). The
LEDs were mounted facing into a plastic sphere, which acted as a diffuser and provided a
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uniform field of illumination. The LEDs were driven by digital counter/timers on the
data acquisition board, and light intensity was varied by pulse width modulation of a 1
kHz square wave as well as neutral density filters moved into the light path. Maximum
output was 5 x 105 photons μm-2 s-1, measured at the focal plane of the slice using an IL1700 radiometer (International Light, Newburyport, MA) and apertures of 100 or 400 μm
(Lenox Laser, Glen Arm, MD)..

Pharmacology experiments
Rabbit retina-sclera preparations were made and pharmacology experiments
performed as described in Chapter 3, except as described below. For dark-adapted
experiments, the whole superior portion of the eyecup was stored in bubbled Ames at
room temperature inside a light-tight chamber for a minimum of 100 minutes. The lighttight chamber consisted of two nested cardboard boxes wrapped in dual layers of
aluminum foil. A rubber tube carrying the O2/CO2 mix was threaded through a small,
hole in the outer box, which was then covered with foil. Secondary silicone tubes fed
into the inner box and bubbled the Ames medium. The light-tight chamber was then kept
in a dark room for the duration of the adaptation. After the adaptation period, the eyecup
was cut into four pieces as described in Chapter 3, except that this was performed under
infrared illumination. Once separated, the pieces were incubated with pharmacologic
agents in bubbled Ames back inside the light-tight chamber
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Immunolabeling
Immunolabeling was performed as described in Chapter 3. Additional
antibodies used were rabbit anti-NR1 (1;100 dilution; Chemicon) and mouse monoclonal
antibodies against PKCα (1:500 dilution; Transduction Laboratories, Lexington, KY) and
kinesin II (1:100 dilution, Convance, Richmond, CA).

Imaging and data quantification
Images presented in Figures 2 and 3 were acquired on a Zeiss LSM-410
confocal microscope with a 63x objective (1.4 N.A.). Alignment for all three channels
and resolution were checked at x8 zoom using 1μm fluorescent spheres (Molecular
Probes, Eugene, OR). The average distribution of synaptic structures around NMDAR
clusters was obtained by clipping sections of the image centered on NMDARs, aligning
these frames and signal averaging for all three channels. Results were displayed as
surface plots using custom software. This is a method to analyze the average distribution
of labeling in the other two channels around a repeated neuronal structure. In this paper,
it was used as a method to assess the average distribution of synaptic ribbons, rod bipolar
terminals, and Cx36 plaques around NMDAR clusters.
All other confocal images were collected on a Zeiss LSM 510 Meta confocal
microscope using a 63x (1.4 N.A.) objective. Imaging settings in the LSM software were
identical where comparisons are made. Cx36 phosphorylation was quantified as the ratio
of the mean intensity of Ser293-P to mCx36 immunofluorescence at individual regions of
interest (ROIs), each identified by the mCx36 label as a single Cx36 gap junction plaque.
ROI identification was performed as described in Chapter 3.
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Five-six images were collected at mid-peripheral eccentricity from each
condition in the pharmacology experiments. The ratio of the mean intensity of Ser293-P
to mCx36 immunofluorescence was calculated for each ROI and averaged across all
ROIs in all images per condition. In this way, we collapsed the phosphorylation data into
one value per condition per animal in order to perform statistical analysis.
Images presented in the figures were collected using identical settings in the
LSM software. Processing was limited to application of a 10% intensity threshold in all
channels to minimize background noise.

Statistical analysis
Unpaired, two-tailed t-tests were used to compare each drug-treated condition
with the control condition from the same animal. Unpaired, two-tailed t-tests were also
used to compare two drug-treated conditions that shared one common drug (such as D1R
agonist condition vs. D1R agonist plus phosphatase inhibitor).

Results
NMDA receptors do not contribute to the light response of AII amacrine cells
Much work has been done to characterize the glutamate-driven ionic currents
present in AII amacrine cells (Hartveit and Veruki, 1997); (Morkve et al., 2002); (Veruki
et al., 2003; Zhou and Dacheux, 2004), but at present it is unclear if the NMDA receptors
on these cells play a role in the response to light. We began this study by reproducing the
NMDA-mediated currents previously characterized by others (Hartveit and Veruki, 1997;
Zhou and Dacheux, 2004). AII amacrine cells were identified for recording in retinal
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Figure 1 | NMDA currents in AII amacrine cells do not contribute to the light
response.
A) Image of an AII amacrine cell targeted for recording under DIC illumination; B)
Lucifer yellow fluorescence in the cell confirms its identity after recording; C) Puffs of
NMDA (500 μM, black bars) in the presence of 4 μM Co2+, 1 μM glycine, 2 μM
strychnine, and 2 μM TTX elicit an outward current in an AII amacrine held at +60 mV;
D) Current responses in an AII held at +60 mV in response to depolarization of a
presynaptic rod bipolar cell. The outward current elicited was almost entirely blocked by
NBQX (20 μM), an AMPA & kainate receptor antagonist. Averaging of 5 recorded pairs
(inset D’) revealed a low amplitude, slow onset current that suggests activation of
extrasynaptic NMDA receptors; E) A 500 ms dim light flash (1 R* rod-1 s-1, black bar)
elicited a 20 mV depoloarization followed by a slight hyperpolarization after light off.
Application of CPP (20 μM), an NMDA receptor antagonist, did not alter the amplitude
or waveform of the light response, indicating that NMDA receptors do not influence light
evoked responses in AII amacrine cells.
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slices by their distinctive small somas and stout primary dendrites that descend through
the inner plexiform layer (IPL) (Figure 1A). Patch pipettes contained fluorescent dyes
for visualization of the cells after recording. Cell identity was confirmed by the existence
of characteristic lobular appendages in sublaminae 2 and 3 of the IPL in addition to fine
dendritic arbors in sublaminae 4 and 5 (Figure 1B). Puffs of NMDA (500 μM) were
applied to the dendritic arbor via puffer pipette. The Ames medium bath was
supplemented with the coagonist glycine (1 μM), Co2+ (4 mM) to block polysynaptic
effects, strychnine (2 μM) to block activation of glycine receptors, and TTX (2 μM) to
block voltage-gated sodium channels on AIIs. At a holding potential of +60 mV AIIs
responded to NMDA puffs with an outward current (Figure 1C). Currents were also
recorded using a ramp protocol that varied the membrane potential of the cell from -60 to
+60 mV in the presence of NMDA. This was repeated with the addition of the NMDA
receptor antagonist CPP (20 μM). Subtraction of the NMDA + CPP current from the
NMDA current alone yielded a J-shaped I-V curve that reversed close to 0 mV
(Supplemental Figure 1), characteristic of NMDA receptors (Dingledine et al., 1999).
These results were consistent across 5 recorded AIIs.
At synapses where AMPA and NMDA receptors colocalize in the
postsynaptic membrane, both receptor types contribute to evoked and spontaneous
EPSCs (Bekkers and Stevens, 1989). Current evidence suggests that spontaneous EPSCs
in AII amacrine cells are mediated solely by AMPA receptors (Veruki et al., 2003),
indicating that NMDA receptors on AIIs may be extrasynaptic. We directly tested
whether evoked glutamate release from rod bipolar cells could activate EPSCs in AII
amacrine cells when AMPA receptors were blocked. To do this we performed dual
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Figure S1 | I-V relationship of NMDA activated conductance on AII amacrine cells.
Shown is an example of the current-voltage relationship of the NMDA activated
conductance (shown in Figure 1). With 4 μM Co2+, 1 μM glycine, 2 μM strychnine and 1
μM TTX in all perfused solutions, the AII was ramped from -60 to +60 mV. Currents
were recorded and averaged in response to 20 voltage ramps. Shown is the difference
current between ramps with NMDA and those with NMDA + CPP, an NMDA receptor
antagonist. Subtraction of the NMDA+CPP current from the current in NMDA alone
yielded a characteristic J-shaped I-V curve that reversed at 0 mV.
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whole-cell patch clamp experiments on rod bipolar cell-AII amacrine cell pairs with and
without the selective AMPA/Kainate antagonist NBQX in the bath. In order to maximize
the possibility of detecting small NMDA-mediated EPSCs, the postsynaptic AII was held
at +60 mV to alleviate the Mg2+ block of NMDA receptors, and the Ames medium was
supplemented as above, with the exception that Co2+ was not included. Rod bipolar cells
were held at -70 mV and stepped to -30 mV, evoking large, fast inward currents in
postsynaptic AIIs (Figure 1D). These were virtually eliminated when NBQX (20 μM)
was included in the bath, and recovered upon washout of the drug, as expected if AMPA
receptors alone are located at the synapse. Similar results were observed in a total of 5
recorded pairs. However, when the currents from all rod bipolar-AII pairs were
averaged, a small, slow inward current was revealed (Figure 1D’). Such low-amplitude,
long-latency currents are characteristic of extrasynaptic NMDA receptors (citations).
This current cannot be explained by electrical input due to spikes in neighboring AIIs, as
TTX (2 μM) was co-applied with NBQX. While it is clear that the majority of rod
bipolar cell input to AIIs is mediated by AMPA receptors, this residual current suggests
that glutamate released from rod bipolar cells may also bind to putative extrasynaptic
NMDA receptors on AII amacrine cells.
We next asked whether the NMDA receptors on AII amacrine cells contribute
to the light response of these neurons by flashing dim light on dark adapted retinal slices
while recording from AIIs in current clamp. It is known that glutamate spillover occurs
at the rod bipolar-AII synapse, as stimulating release of glutamate from one rod bipolar
elicits a glutamate transporter-coupled anion current in neighboring rod bipolar cells
(Veruki et al., 2006). We therefore sought to activate the majority of rod bipolar cells in
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Figure 2 | NMDA receptors on AII amacrine cells are extrasynaptic.
A) and A’) High magnification images show the location of NMDA receptors, labeled by
antibodies against the NR1 subunit (green), on AII amacrine cell dendrites, labeled by
calretinin antibodies (blue). Arrows indicate the locations of several NR1 puncta. B) and
B’) Rod bipolar cell terminals, labeled by antibodes against PKCα (red), associated with
the same AII dendrites. The arrows indicating the positions of the NR1 puncta show that
NMDA receptors on AIIs are not associated with rod bipolar cell inputs to the AII
dendrites. C) and C’) As described in A, but from a different piece of tissue. D) and D’)
Labeling of synaptic ribbons by kinesin II antibodies (red) in bipolar cell terminals; the
arrows indicating the positions of the NR1 puncta show that NMDA receptors on AIIs are
not associated with sites of glutamate release. For contrast, compare with the association
of kinesin II labeling and AMPA receptors on AII dendrites (Li et al., 2002). Scale bar in
B’ is 5 μm.
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the slice in hopes of maximizing the chances of spillover glutamate binding to putative
extrasynaptic NMDA receptors. To accomplish this we chose a light flash intensity of 1
R* rod-1 s-1, which will activate multiple rod bipolar cells presynaptic to each AII
amacrine cell. We found that the AII response to a 500 ms light flash was unaffected by
CPP (20 μM) (Figure 1E), indicating that NMDA receptors do not contribute to the AII’s
light response even when it receives input from multiple rod bipolar cells. This is
perhaps unsurprising given the very large ratio of AMPA to non-AMPA current
stimulated by glutamate release from a single rod bipolar cell (Figure 1D). As this
experiment’s results did not support a traditional role for the NMDA currents in AII
amacrine cells (i.e. contribution to the light response), we next performed several
immunolabeling experiments to localize the NMDA receptors on AIIs. The rationale for
this was that the anatomical location of the receptors might hint at their function in AII
physiology.

NMDA receptors on AII amacrine cells are extrasynaptic
NMDA receptors are heterotetramers composed of two NR1 subunits and two
NR2 subunits; NR2 subunits are further divided in four types, A-D, all of which are
expressed in the retina (Grunder et al., 2000). Whole mount retinas were labeled with
polyclonal antibodies against the NR1 subunit in order to label the maximum number of
NMDA receptors at once for our localization of NMDA receptors on AII amacrine cells.
AII amacrine cells were labeled diffusely with antibodies against the Ca2+-binding
protein calretinin (Massey and Mills, 1999). Finally, we included antibodies against
PKCα or kinesin II to label rod bipolar cells or synaptic ribbons in presynaptic bipolar
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Figure S2 | Spatial fluorescence intensity averages show that NMDA receptors on
AIIs are not associated with rod bipolar terminals or presynaptic ribbons.
A) Signal averaging analysis shows a random pattern of PKC immunoreactivity in
relation to NR1 puncta associated with AIIs. There is no central peak in the PKC plot
corresponding to the two central peaks in the NR1 and calretinin plots. Instead, the PKC
plot is flat indicating no association with NR1 or calretinin. B) Signal averaging analysis
shows a random pattern of kinesin II immunoreactivity in relation to NR1 puncta
associated with AIIs. There is no central peak in the kinesin II plot corresponding to the
two central peaks in the NR1 and calretinin plots. In fact, the kinesin II plot is flat,
indicating that nearly total absence of label in the sampling boxes. The size of the
sampling squares used in the analysis was 2 μm, indicating that ribbons and NR1 puncta
were not consistently found within 1 μm of each other.
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cells, respectively. NR1 labeling was localized on the fine dendrites of AII amacrine
cells in sublamina b of the IPL (Figure 2, A & C). AIIs were nearly devoid of NR1
labeling in sublamina a, where the lobular dendrites of the AII ramify (data not shown).
Arrows in Figure 2 were placed to indicate the location of NR1 labeling associated with
AII amacrine cell dendrites. Examination of rod bipolar cell labeling (Figure 2B) showed
that most NMDA receptors on the AII dendrites are not closely apposed to rod bipolar
cell terminals. Further investigation of the synaptic ribbon labeling (Figure 2D) revealed
that most NMDA receptors on AIIs were not closely apposed to sites of glutamate release
from any nearby bipolar cells. Since the kinesin II labels synaptic ribbons in both rod
and cone bipolar cells, it appears that the NMDA receptors on AIIs do not receive direct
synaptic input at all. This interpretation is reinforced when contrasted against a similar
immunolabeling experiment showing close association of kinesin II-labeled ribbons and
synaptic AMPA receptors on AII amacrine cells (Li et al., 2002).
To further analyze the relationship between NR1 puncta and rod bipolar cell
terminals or synaptic ribbons, square sampling boxes (2 μm per side) were placed
centered on NR1 puncta located on AII dendrites (see Methods). The spatial intensity
distributions of fluorescence for each antibody was calculated and then averaged across
all sampling boxes (Supplemental Figure 2). The flatness of the PKC and kinesin II
channel averages indicates that there was no reliable relationship between NR1 labeling
on AII dendrites and presynaptic rod bipolar cells or glutamate release sites in nearby
bipolar cells. All together, this evidence further argues that NMDA receptors on AII
amacrine cells are localized extrasynaptically.
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Figure 3 | NMDA receptors colocalize with Cx36 gap junctions on AII amacrine
cells.
A) Triple labeling shows AII amacrine cells labeled by calretinin antibodies (blue), Cx36
gap junctions (red), and NMDA receptors labeled with NR1 antibodies (green). White
spots indicate the colocalization of all strong signals in all three channels. B) Arrows
indicate the locations of selected Cx36 gap junctions. C) The arrows showing the
locations of Cx36 gap junctions show that NR1 puncta are colocalized with most Cx36
gap junctions on the AII network. Scale bar in A is 10 μm.
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NMDA receptors on AII amacrine cells colocalize with Cx36 gap junctions
Although NMDA receptors do not appear to participate in the light response
of AII amacrine cells in the rod-photoreceptor operating range (Figure 1E), we showed
that blockade of AMPA receptors on AIIs revealed a small residual current (Figure 1D’).
This residual current resembled the profile for extrasynaptic NMDA receptors in that it
was small, had a long latency to onset, and did not appear to inactivate. It remains
possible that glutamate spillover might activate very small currents mediated by
extrasynaptic NMDA receptors in the AII amacrine cell that minimally influence the
voltage response of the cell to light, but which cause significant Ca2+ influx in a very
local domains. Both NMDA receptor activation and Ca2+ influx are required for activitydependent potentiation of Cx35-mediated electrical coupling at the mixed
electrical/chemical synapses in goldfish Mauthner cells (Yang et al., 1990; Pereda and
Faber, 1996) (Cx35 is the non-mammalian ortholog of mammalian Cx36). Since
increasing background illumination increases coupling between AII amacrine cells
throughout the rod-photoreceptor operating range (Bloomfield et al., 1997; Bloomfield
and Volgyi, 2004), we investigated whether NMDA receptors were localized near Cx36
gap junctions on AIIs, and thus in a position to influence gap junctional coupling in the
AII network. Whole mount retinas were labeled with antibodies against calretinin, the
NR1 subunit of NMDA receptors, and Cx36 gap junctions (Figure 3A). Nearly all Cx36
gap junctions on AII amacrine cell dendrites were colocalized or closely associated with
NR1 puncta (Figure 3B). Arrows in Figure 3 indicate locations on AII dendrites where
Cx36 gap junctions colocalize with strong NR1 puncta. As before, we analyzed the
spatial intensity distribution of fluorescence for each antibody channel, with each square
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Figure S3 | Spatial fluorescence intensity averages show that Cx36 gap junctions are
associated with NMDA receptors on AII amacrine cells.
A) Signal averaging of 228 Cx36 plaques from a larger area of retina that included the
area shown in Figure 3 was used to analyze the association between Cx36 and NR1. 5.4
μm sampling boxes were placed around Cx36 plaques on AII dendrites. The NR1 signal
was hidden to avoid bias. No distinction was made between plaques at AII dendritic
crossings and plaques on single dendrites. The existence of 3 distinct peaks from all
three signals indicates that the three structures are repeatedly associated. Loss of a
central peak upon rotation of the NDMAR1 channel 90 degrees demonstrates that the
association of NR1 and Cx36 did not occur by chance. B) For comparison, sampling
boxes were placed around NR1 clusters on AIIs while the Cx36 signal was hidden. With
this sampling constraint, again all three signals have a correlated central peak, indicating
that Cx36 and NR1 indeed that NMDA receptors on AII amacrine cells are very regularly
associated with Cx36.
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sampling box centered on Cx36 gap junctions on AIIs (Supplemental Figure 3A). The
central peak seen in all three channel averages indicates the association of all three
signals. NMDA receptors are expressed by a number of retinal neurons with dendrites
near to those of AII amacrine cells, such as ON retinal ganglion cells (Zhang and
Diamond, 2006; Kalbaugh et al., 2009), and much of the NR1 labeling seen is not on AII
amacrine cells. The association of Cx36 gap junctions with NR1 puncta was not due to
chance colocalization of the more numerous NR1 puncta, however, as 90° rotation of the
NR1 channel relative to the other two channels abolished the associated central peak in
the spatial average. As an independent measure we also examined the spatial average
centered around the NR1 puncta. The resulting central peak in the Cx36 channel
indicates a strong tendency for NR1 puncta at this level of the retina to colocalize with
Cx36 gap junctions (Supplemental Figure 3B). Thus, NMDA receptors are appropriately
localized to influence the coupling state of the AII amacrine network by modulating
Cx36 gap junctions.

Blockade of NMDA receptors and inhibition of CamKII reduce phosphorylation of
Cx36 on AII amacrine cells
In order to test the functional significance of NMDA receptor colocalization
with Cx36 gap junctions, we used an experimental paradigm we previously established to
assess the coupling state of Cx36 gap junctions by examining the relative
phosphorylation state of Cx36 at Ser293 (Cx36-P) (Kothmann et al., 2009). Using this
paradigm, we found that increased phosphorylation of Cx36 at Ser293, a site that
regulates coupling through these gap junctions (Ouyang et al., 2005), is strongly
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Figure 4 | Blockade of NMDA receptors and inhibition of CamKII reduce
phosphorylation of Cx36 gap junctions on AII amacrine cells.
A) – A”) Phosphorylation of Cx36 at Ser293 is heterogeneous in light-adapted retina. B)
– B”) Blockade of NMDA receptors (CPP, 10 μM) reduces phosphorylation of Cx36 at
Ser293. C) – C”) Blockade of AMPA/kainate (NBQX, 10 μM) and NMDA receptors
has little additional effect over blockade of NMDA receptors alone. D) – D”) Inhibition
of CamKII (KN-93, 10 μM) reduced phosphorylation of Cx36 at Ser293. E) Summary of
experiments (n = 4) shows that blockade of NMDA receptors significantly reduces mean
phosphorylation of Cx36 on AII amacrine cells. Additional blockade of AMPA receptors
does not significantly increase the magnitude of this effect. Inhibition of CamKII reduces
phosphorylation of Cx36 to a similar extent as NMDA receptor blockade. F) The
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experiments summarized in E were repeated with antagonist of dopamine D1 receptors
(SCH23390, 50 μM) in the bath (n = 6). As shown previously, antagonism of D1
receptors increased mean phosphorylation of Cx36 on AIIs. It did not prevent the effects
of NMDA receptor blockade or CamKII inhibition, indicating that both of the effects are
independent of dopaminergic input to AII amacrine cells. Analysis was performed on
single optical sections; images presented are 1 μm-deep z-stacks. Error bars are SEM, *
p < 0.05, ** p < 0.01. Scale bar in D is 10 μm.
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associated with increased coupling in the AII amacrine cell network. For the current
experiments the superior portion of a light-adapted rabbit eyecup was cut into four retinasclera pieces with a razor blade. These were incubated for 20 minutes in control Ames or
Ames with glutamate receptor antagonist(s) added, and changes in phosphorylation were
measured using an antibody specific for phospho-Ser293-Cx36 (Kothmann et al., 2007).
Cx36-P was quantified as the average ratio of phospho-Ser293-Cx36 antibody
fluorescence to monoclonal Cx36 antibody fluorescence at each individual gap junction
plaque (for full details on Cx36-P quantification, see Methods). Phosphorylation of Cx36
plaques on AII amacrine cells is heterogeneous in light adapted retina (Figure 4A).
Application of the NMDA receptor antagonist CPP (10 μM) reduced mean Cx36-P by
2.5-fold (Figure 4B, E), indicating that activation of NMDA receptors in light-adapted
retina acts to increase phosphorylation of Cx36. Co-application of the AMPA receptor
antagonist NBQX (10 μM) with CPP caused a slightly more robust reduction in Cx36-P,
though not significantly different from CPP alone (Figure 4C, E).
Dopamine is a well-known regulator of coupling in the AII amacrine cell
network (Hampson et al., 1992), with increased dopamine signaling causing reduced
Cx36-P and reduced coupling (Kothmann et al., 2009). We tested whether the effect of
NMDA receptor blockade on Cx36-P was due to modulation of neurons influencing
dopamine release in the retina by repeating the experiment with the dopamine D1
receptor antagonist SCH23390 (50 μM) in the bath. D1 receptor blockade alone
increased Cx36-P, as we reported previously (Kothmann et al., 2009), but it did not
prevent the reduction in Cx36-P caused by CPP (Figure 4F). As before, inclusion of
NBQX in the bath had no additional effect. Thus, blockade of NMDA receptors is
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Figure 5 | Activated CamKII “hotspots” colocalize with Cx36 gap junctions on AII
amacrine cell dendrites.
A) A single optical confocal section showing that activated CamKII, identified by
antibodies against phospho-Thr286-CamKII (green) is widely distributed throughout the
inner plexiform layer (IPL) of light-adapted retina. Strong labeling is seen in a ring
around the soma of a calretinin-labeled AII amacrine cell (red) in the inner nuclear layer
(INL), as well as in its stout primary dendrite (yellow). B) A 6 μm-deep z-stack of the
calretinin label showing more fully the primary dendrite of the AII descending through
the IPL and branching into fine dendrites. C) A single optical confocal section showing
only the activated CamKII label. D) – D’”) High magnification views of the area
enclosed in the white rectangle in A. These single optical confocal sections show crosssections through several of the fine dendrites of the AII amacrine cell (D’), and the Cx36
gap junctions (blue) on them (D”). Several of the Cx36 gap junctions are indicated by
arrowheads, and when the activated CamKII label is viewed in isolation (D’”), it is
evident that several of these Cx36 gap junctions are colocalized with “hotspots” of
activated CamKII. Scale bars in A and B are 5 μm, scale bar in D is 2 μm.
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sufficient to reduce phosphorylation of Cx36 in AII amacrine cells in light adapted retina,
and is not due to modulation of the dopaminergic pathway which also regulates Cx36-P
in AIIs.
In addition to requiring NMDA receptor activation and Ca2+ influx, the
activity-dependent potentiation of Cx35-mediated electrical coupling in Mauthner cells
also requires CamKII activation (Pereda et al., 1998). We therefore also tested if
inhibition of CamKII influenced the phosphorylation state of Cx36 gap junctions on AII
amacrine cells. Application of the CamKII inhibitor KN-93 (10 μM) reduced mean
Cx36-P to a similar extent as blockade of NMDA receptors (Figure 4D, E). As was the
case with NMDA receptor blockade, the reduction in Cx36-P caused by KN-93 persisted
with dopamine D1 receptor antagonist in the bath (Figure 4F), indicating that CamKII
inhibition reduces Cx36-P independent of dopamine signaling. These experiments
indicate that in light-adapted retina, activation of NMDA receptors and CamKII activity
are both required to maintain phosphorylation of Cx36 at Ser293.

Activated CamKII colocalizes with Cx36 gap junctions in AII amacrine cells
CamKII is a common mediator of activity-dependent plasticity in neurons
(Colbran and Brown, 2004). In order to maintain specificity of targeting, CamKII is
localized in postsynaptic density found at glutamatergic synapses. CamKII binds to
multiple subunits of the NMDA receptor as well as to Cx36 gap junctions, and this
binding is often facilitated by or requires autophosphorylation of the kinase at Thr286
(Colbran, 2004; Alev et al., 2008). We utilized antibodies against phospho-Thr286CamKII, calretinin, and Cx36 to determine if the activated kinase is localized near Cx36
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Figure 6 | Activation of NMDA receptors drives phosphorylation of Cx36 gap
junctions on AII amacrine cells.
A) and A’) Dark adaptation of the retina for 2 hours greatly reduced phosphorylation of
Cx36 gap junctions at Ser293. B) and B’) Application of NMDA (50 μM) drove
increased phosphorylation of Cx36 at Ser293. C) and C’) Addition of AMPA (5 μM)
and NMDA drove increased phosphorylation of Cx36 at Ser293 more strongly than
NMDA did alone. D) and D’) Interestingly, application of AMPA alone also drove
increased phosphorylation of Cx36 at Ser293. E) Summary of experiments (n = 6) shows
that addition of NMDA to the bath drove phosphorylation of Cx36 back to control, light
adapted levels (compare with Figure 4E). Application of AMPA drove increased
phosphorylation as much as NMDA did. Addition of AMPA and NMDA drove
phosphorylation significantly higher than NMDA or AMPA alone. Analysis was
performed on single optical sections; images presented are 1 μm-deep z-stacks. Error
bars are SEM, ** p < 0.01. Scale bar in D is 10 μm.
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gap junctions in AII amacrine cells. In vertical sections from light-adapted retina there
was strong phospho-Thr286-CamKII labeling throughout the IPL (Figure 5). The somas
of a number of cells were ringed with phospho-Thr286-CamKII labeling, including many
AII amacrine cells. Activated CamKII labeling was often strong in the primary dendrites
of AIIs as well. Close inspection of the fine dendrites of AIIs in sublamina b of the IPL
showed that hotspots of phospho-Thr286-CamKII labeling were often colocalized with
Cx36 gap junctions on the AII network. These results indicate that activated CamKII is
appropriately localized to influence the phosphorylation state of Cx36 gap junctions on
AII amacrine cells, either by direct phosphorylation of the protein of by modulation of
other proteins regulating phosphorylation of Cx36.

NMDA and AMPA drive phosphorylation of Cx36 on AII amacrine cells
We next asked whether activation of NMDA receptors could drive increased
phosphorylation of Cx36 gap junctions. For these experiments we began by darkadapting the superior portion of a rabbit eyecup for 100 minutes. The purpose for this
was twofold. First, AII amacrine cells in well dark-adapted retinas have been shown to
be relatively uncoupled (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004). Thus
we wished to investigate the phosphorylation state of Cx36 in AIIs after our retina-sclera
preparations were dark-adapted. Second, as rod bipolar cells are ON-type bipolar cells
and release glutamate in response to light, using dark-adapted retinas allowed us to
examine the effects of NMDA application on relatively quiescent AII amacrine cells.
After the initial dark-adaptation period, the eyecup was removed from the light-tight
chamber under infrared illumination and cut into four retina-sclera pieces with a razor
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Figure 7 | Activation of ON-bipolar cells by CPPG or background light increment
drive increased phosphorylation of Cx36 gap junctions on AII amacrine cells.
A) and A’) Dark adaptation of the retina for 2 hours greatly reduced phosphorylation of
Cx36 gap junctions at Ser293. B) and B’) Depolarization of ON-type bipolar cells in
darkness via antagonism of mGluR6 receptors (CPPG, 200 μM) drove increased
phosphorylation of Cx36 at Ser293. C) and C’) Exposure of dark-adapted retinas to
photopic full-field background illumination also drove increased phosphorylation of
Cx36 at Ser293. D) and D’) The effect of increased background illumination was
abolished when activation of ON-type bipolar cells was inhibited (L-AP4, 50 μM). E)
Summary of experiments (n = 5) shows that activation of ON-type bipolar cells drove
phosphorylation of Cx36 back to control, light adapted levels (compare with Figure 4E).
Exposure of dark-adapted retinas to photopic background illumination drove
phosphorylation to a similar extent as ON-type bipolar cell activation did. Activation of
mGluR6 receptors on ON-type bipolar cells completely prevented the effects of increased
background illumination, and actually reduced phosphorylation below control, darkadapted levels (but compare with dark-adapted levels in Figure 5E). Analysis was
performed on single optical sections; images presented are 1 μm-deep z-stacks. Error
bars are SEM, ** p < 0.01. Scale bar in D is 10 μm.
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blade. Pieces were separated into control Ames or Ames with glutamate agonist(s) added
and placed back into the light-tight chamber for 20 additional minutes, after which
phosphorylation of Cx36 was measured as before. Dark-adapting the retina for 120
minutes led to a dramatic reduction in Cx36-P (Figure 6A), in good agreement with the
previous reports that AIIs are uncoupled in well dark-adapted retinas (Bloomfield et al.,
1997; Bloomfield and Volgyi, 2004). Mean Cx36-P in dark-adapted retina was
approximately 10-fold less than typical values obtained from in light-adapted retinas
(Figure 4E). Addition of NMDA (50 μM) to the bath increased Cx36-P back to typical
light-adapted levels (Figure 6B), indicating that NMDA receptor activation drives
phosphorylation of Cx36. Addition of both AMPA (5 μM) and NMDA (50 μM) to the
bath increased Cx36-P significantly above the levels cause by application of NMDA
alone (Figure 6C). Interestingly, application of AMPA (5 μM) alone also increased
Cx36-P (Figure 6D). These experiments support a role for NMDA-receptor mediated
modulation of AII amacrine cell coupling via increased phosphorylation of Cx36 in AII
amacrine cells. It is unclear from these experiments how AMPA receptors drive
increased Cx36 phosphorylation. One simple explanation is that AMPA receptor-driven
depolarization of AII amacrine cells may facilitate opening of NMDA receptors near
Cx36 gap junctions, although these experiments cannot rule out other alternatives.

ON-Bipolar cell activation and background light increments drive phosphorylation
of Cx36 on AII amacrine cells
Finally, we tested whether activation of ON-type bipolar cells could drive
increased phosphorylation of Cx36 gap junctions on AII amacrine cells. Rod bipolar
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cells provide the major glutamatergic input to AIIs on their fine dendrites, where the
Cx36 gap junctions are located (Strettoi et al., 1992). The experimental setup was the
same as described for the above experiments using dark-adapted retina. The mean level
of Cx36-P was slightly higher in dark-adapted control pieces than in the above
experiments (Figure 7A), but was still well reduced below levels seen in light-adapted
retinas. Addition of CPPG (200 μM), an mGluR6 antagonist which causes depolarization
in ON-type bipolar cells (citations), significantly increased mean Cx36-P (Figure 7B, E)
to levels similar to those in light-adapted retina. At the same time as one retina-sclera
piece was placed in Ames with CPPG added, another was place in Ames with L-AP4, an
agonist of the mGluR6 receptor which hyperpolarizes ON-type bipolar cells. Then, after
the control (dark-adapted) and CPPG retina-sclera pieces were re-secured within the
light-tight chamber, the remaining two pieces (in either control Ames or Ames with LAP4) were removed from the dark room and placed under the light-source (fluorescent
lab lighting) used for light-adapted experiments for 15 minutes. This period of increased
background illumination also significantly increased Cx36-P (Figure 7C, E) back to
typical light-adapted levels. Inclusion of L-AP4 in the bath completely prevented this
increase, and actually significantly reduced phosphorylation below control (dark-adapted)
levels (Figure 7D, E). That pharmacological inactivation of ON-type bipolar cells
reduced phosphorylation further than dark-adaptation alone suggests that in this set of
experiments dark-adaptation was incomplete, perhaps due to exposure to dim pointsources of light in the dark room when the eyecup was removed from the light-tight
chamber. This is further supported by the observation that dark-adaptation in previous
experiments was sufficient to reduce Cx36-P to the same levels as seen in L-AP4 in these
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experiments. These experiments provide evidence that increments in background
lighting, mediated by ON-type bipolar cells, drive increased phosphorylation of Cx36 on
AII amacrine cells. This agrees nicely with previous experiments that demonstrated
increased coupling between AII amacrine cells under increasing background illumination
(Bloomfield et al., 1997; Bloomfield and Volgyi, 2004).

Discussion
Although NMDA currents have been described in AII amacrine cells before
(Hartveit and Veruki, 1997; Zhou and Dacheux, 2004), the physiological significance of
these currents remain unknown. The results of the present study now describe a role for
these NMDA receptors in driving increased phosphorylation of Cx36 gap junctions on
AIIs, thereby increasing cell-cell coupling in the AII amacrine cell network. Indeed,
driving increased phosphorylation of Cx36 under scotopic background illumination may
be the primary purpose of NMDA receptors on AIIs, as our evidence indicates that they
do not contribute to the light response of the cells under these conditions.
Our evidence indicates that the AII’s NMDA receptors are extrasynaptic, as
EPSCs in AIIs triggered by voltage steps in rod bipolar cells were nearly abolished by
AMPA receptor blockade. This was confirmed by immunolabeling showing no
relationship between NMDA receptors on AIIs and rod bipolar terminals or synaptic
ribbons. It is also in agreement with electrophysiological data reported by others
showing that spontaneous EPSCs in AIIs were solely mediated by AMPA receptors
(Veruki et al., 2003). However, averaging of all rod bipolar-AII pairs did show a lowamplitude, NBQX-resistant current with slow kinetics, as would be predicted for
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extrasynaptic NMDA receptors (citations). Since spillover of glutamate does occur at the
rod bipolar-AII synapse (Veruki et al., 2006), it is possible that this residual current
represents binding of spillover glutamate to the AIIs NMDA receptors. Future
experiments must be done to confirm this.
We found that the Cx36 and NMDA receptors are regularly colocalized or
closely associated in AII dendrites, and a functional relationship between them was
revealed by blockade of NMDA receptors in light-adapted retina, which reduced
phosphorylation of Cx36 at Ser293. This reduction in Cx36 phosphorylation indicates
reduced coupling between AII amacrine cells (Kothmann et al., 2009). The relationship
between NMDA receptors and Cx36 was confirmed by the finding that activation of the
receptors drives increased phosphorylation of Cx36 in dark-adapted retina. This is very
interesting, as AIIs should be hyperpolarized in the dark-adapted preparation. In the
absence of any depolarizing input, how do the NMDA receptors open? It is known that
NMDA receptors containing the NR2C or NR2D subunits are 5- to10-fold less sensitive
to the Mg2+ block than are the other NMDA receptors (Monyer et al., 1994). For
instance, NR1-NR2A current responses to NMDA are reduced by ~80% by 0.5 mM Mg2+
at a holding potential of -60 mV, whereas NR1-NR2C responses are only reduced by
~50% (Monyer et al., 1992). Considering the physiological Mg2+ concentration in our
Ames solution (1.2 mM Mg2+), we would predict that NMDA receptors on AIIs are NR1NR2C or NR1-NR2D heteromers. It is also known that ambient extracellular glutamate
in hippocampal slices is of sufficiently high concentration to activate NMDA receptors
and contributes to the excitability of pyramidal neurons (Sah et al., 1989). Similarly, in
retina NMDA receptors contribute to the basal noise in retinal ganglion cells (Gottesman
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and Miller, 2003). In both of these examples the effect is observed at membrane
potentials of -70 mV or more, well below the resting membrane potential of an AII (-46
mV, (Dunn et al., 2006). Our data indicate that despite the lack of direct glutamatergic
input on the AIIs fine dendrites in dark-adapted retina, NMDA receptors are still
responsive to exogenous agonist, potentially because of receptor subtype and/or the
relatively depolarized resting membrane potential of AII amacrine cells.
It is more straightforward to imagine the circumstances that would activate
NMDA receptors on AII amacrine cells in vivo under scotopic conditions, when they are
depolarized directly by glutamate released by rod bipolar cells. Based on our results, we
postulate that extracellular NMDA receptors, with their exceptional high affinity for
glutamate (Olverman et al., 1984), sense the local excitation history in the vicinity of
Cx36 gap junctions on AII dendrites. Such a situation fits with the observed increase in
AII-AII coupling when background illumination exceeds the rod photoreceptor threshold,
as this is when rod bipolar cells presynaptic to AIIs begin to release glutamate and AIIs
are transiently depolarized by AMPA receptor activation. Further increases in
background illumination within the scotopic range would cause larger numbers of rod
bipolar cells to be active at a given time, further increasing extracellular glutamate and
AII depolarization and thus further driving increased AII-AII coupling, as has been
observed (Bloomfield et al., 1997; Bloomfield and Volgyi, 2004). Our data support such
a scenario, as pharmacological activation of ON-type bipolar cells and activation by a
background light increment both drive increased phosphorylation of Cx36 gap junctions
on the AII network, indicating increased AII-AII coupling.
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In light-adapted retina, AIIs receive significant input from coupled ON cone
bipolar cells, sufficient to drive AII-mediated inhibition of OFF bipolar and ganglion
cells (Manookin et al., 2008; Murphy and Rieke, 2008; Munch et al., 2009; van Wyk et
al., 2009). Depolarization from this input should facilitate NMDA receptor activation by
ambient and/or spillover glutamate, leading to increased Cx36 phosphorylation. This will
be opposed by dopamine-driven dephosphorylation of Cx36 in daytime, light-adapted
retina (Kothmann et al., 2009). The conflicting actions of these two pathways likely
account for the heterogeneous phosphorylation of Cx36 gap junctions that we observe in
light-adapted retina-sclera preparations. It is unknown if this same heterogeneity exists
in vivo, as the bath volume (4 mL) used in our pharmacology experiments may dilute
effective dopamine concentrations. In addition or perhaps alternatively, the observed
heterogeneity may be due to differential regulation of AII-AII gap junctions and AII-cone
bipolar gap junctions, as has been demonstrated (Mills and Massey, 1995). Our
techniques do not currently distinguish between these gap junctions, but it seems likely
that AII-AII gap junctional coupling may be preferentially decreased while AII-cone
bipolar gap junctional coupling remains somewhat intact, given the existence of ON cone
bipolar driven inhibition of ganglion cells via AII amacrine cell activation (Manookin et
al., 2008; Murphy and Rieke, 2008; Munch et al., 2009; van Wyk et al., 2009) and the
lesser effect of dopamine on AII-cone bipolar gap junctions (Xia and Mills, 2004). This
could be due to expression of Cx45 on the ON bipolar cell side of these junctions (Han
and Massey, 2005; Dedek et al., 2006), or the selective impact of cGMP-dependent
signaling on the ON bipolar cell side of the gap junction only (Mills and Massey, 1995;
Xia and Mills, 2004), or both.
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Our data show that the effects of glutamate receptor blockade on Cx36
phosphorylation are not due to indirect modulation of extracellular dopamine in the
retina, as they persist when the dopaminergic input to AII amacrine cells is blocked.
Further evidence for this comes from the same set of experiments, since blockade of
AMPA and NMDA receptors should reduce activation of the dopaminergic amacrine cell
(Zhang et al., 2007; Hoshi et al., 2009), which would reduce extracellular dopamine and
should increase Cx36 phosphorylation on AIIs (Kothmann et al., 2009). However, we
observe the opposite; Cx36 phosphorylation was reduced in these experiments, whether
or not D1 dopamine receptors were blocked. Thus we conclude from the experiments
presented here and those conducted previously (Kothmann et al., 2009) that two
pathways, one driving increased phosphorylation and mediated by NMDA receptor
activation and the other driving decreased phosphorylation and mediated by dopamine
signaling, are responsible for the inverted U-shaped pattern of coupling in the AII
amacrine cell relative to background illumination. Furthermore, we infer from our data
that there must be constitutive phosphatase activity which drives dephosphorylation of
Cx36 in dark-adapted retina. The identity of the phosphatase and whether its activity is
modulated remains unknown at present.
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Chapter 5

Discussion
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The experiments detailed in the previous chapters have significantly advanced
our understanding of how signaling methods in the retina contribute to the regulation of
gap junctional coupling in a particular retinal neuron, the AII amacrine cell. In order to
reach this new level of understanding, we first developed and characterized phosphospecific antibodies against key residues of the gap junction protein Cx36. We then
showed that light adaptation state and acute light exposure modulate the phosphorylation
state of these residues in fish retina. These initial experiments highlighted the need for a
method to study a retinal neuron expressing Cx36 that we could repeatedly identify. We
chose the AII amacrine cell of mammalian retina for further study because it is easily and
diffusely immunolabeled by antibodies against calretinin and because its coupling state is
strongly modulated by dopamine signaling. Using rabbit retina to study regulation of the
AII amacrine cell coupling we described the relationship between phosphorylation of
Cx36 and coupling through these gap junctions. We discovered that dopaminestimulated uncoupling of the AII is, as predicted, mediated by PKA activation, but that
this pathway triggers dephosphorylation of Cx36 the requires activation of PP2A. Our
experiments in this system also indicated that phosphorylation appears to modulate
coupling by altering the channel properties of Cx36, rather than by alteration of
trafficking of the protein. They also indicated that coupling is regulated locally at the
level of individual gap junction plaques, rather than on a cell-by-cell basis. Finally, we
demonstrated that increased coupling between AII amacrine cells is driven by activation
of NMDA receptors and activation of CamKII. This increase in coupling was caused by
activation of ON type bipolar cells by light increments.
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Our findings show that two pathways, dopamine D1 receptor signaling and
NMDA receptor activation, drive phosphorylation of Cx36 in opposite directions in AII
amacrine cells. Together these two pathways can account for the characteristic inverted
‘U’-shaped pattern of AII amacrine cell coupling in relation to background illumination.
Additionally, we found that dark-adaptation strongly reduced Cx36 phosphorylation.
These observations, along with the presence of two diametrically opposed pathways,
provide the first independent confirmation of the inverted ‘U’-shaped coupling-light
relationship.
Horizontal cells in the rabbit retina also display an inverted ‘U’-shaped
coupling pattern in relation to background illumination (Xin and Bloomfield, 1999), and
are also uncoupled by dopamine through D1 receptor-like signaling (Piccolino et al.,
1984; Lasater, 1987). Based on these similarities to the AII amacrine cell network, we
would predict that they also show increased coupling driven by presynaptic activity in
photoreceptors. Regulation of horizontal cell coupling through phosphorylation of gap
junction proteins they express, such as connexin 50 (O'Brien et al., 2006), remains a
viable hypothesis at present. However, since neither horizontal cell uses Cx36 gap
junctions, the exact intracellular cascades leading to increased coupling would not
necessarily be the same. Indeed, other work in our lab has shown that regulation of
coupling between zebrafish cone photoreceptors is also dependent on dopamine
signaling, but that PKA activation increases coupling, exactly opposite of what we
observe in AII amacrine cells (O'Brien et al., 2004). Coupled with our results presented
here, it becomes clear that regulation of Cx36 is cell-type specific, and must be studied
further on a cell-by-cell basis.
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Many questions still remain about the role of phosphorylation in regulating
Cx36-mediated coupling. Does phosphorylation itself alter the conformation of the
protein, thereby changing the conductance or open probability of the channel?
Alternatively, does it alter the affinity of Cx36 for protein binding partners, which then
modulate coupling? Indeed, the two possibilities are not mutually exclusive, but solving
them presents numerous technical challenges requiring careful biochemistry,
electrophysiology, and structural studies.
Further questions exist about coupling in the AII amacrine cell network as
well. Of great interest is whether regulatory pathways within the AII amacrine cell
selectively modulate AII-AII gap junctions differently than they regulate AII-cone
bipolar gap junctions. Anecdotally, I have observed that antagonism of NMDA receptors
often leaves a population of small gap junctions on AIIs well phosphorylated. Many of
these gap junctions do not appear to be at AII dendritic crossings, indicating that they are
likely to be AII-cone bipolar gap junctions. Future studies are needed to determine if this
is a reliable effect, and will require careful analysis and more concrete identification of
AII-cone bipolar gap junctions. Additionally, before concluded differential regulation
within AII amacrine cells, it must be shown that any selective effect of NMDA receptor
antagonism is not selectively modulating Cx36 hemichannels on the bipolar cell side of
the gap junction. Such channels have been reported in ON-cone bipolar cells that appear
to be coupled to AIIs (Han and Massey, 2005). Most studies agree that Cx45 is
expressed by the majority of bipolar cell types that couple to AIIs and forms heterotypic
gap junctions with Cx36 on the AII side (Han and Massey, 2005; Maxeiner et al., 2005;
Dedek et al., 2006), but the question of whether the AII-cone bipolar gap junctions are
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homotypic, heterotypic, or Cx36/Cx45 bi-homotypic is still somewhat debated (Li et al.,
2008).
The experiments presented in this work now provide a logical, integrated
framework for studying regulation of Cx36-mediated coupling in other neuronal systems,
where it is widely expressed, as well as in pancreatic β cells where it is involved in
regulation of insulin secretion (Serre-Beinier et al., 2008; Wellershaus et al., 2008). In
these systems, coupling can now be easily assessed through use of the phospho-specific
antibodies developed and used in this work. Additionally, our results explain the
mechanisms that underlie long-standing yet enigmatic observations of regulation of AII
amacrine cell coupling by background illumination levels.
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